CorVel Corporation
2013
Annual Report
and Form 10K
A Community
Connected by Care.®
As a national provider of innovative risk management
solutions, CorVel helps employers, third party
administrators, insurance companies and government
agencies control costs and achieve positive outcomes.
Letter to Shareholders
The last year was a time of continuing evolution at CorVel. Our full service workers’ compensation
solution, Enterprise Comp, continued to grow rapidly. Carrier and broker endorsements helped
greatly to increase new business opportunities. Liability claims management services expanded
as did analytic capabilities to proactively combat industry-wide issues of prescription costs,
narcotics abuse and pain management.
The market for CorVel’s services improved as the insurance market hardened. The new Federal
Healthcare Reform encourages payors to seek all available means of controlling costs, which in
turn has increased interest in CorVel’s services for the non-occupational segment of healthcare.
Hospital and facility medical review volumes paused as insurers repositioned their medical
review programs in preparation for the Affordable Healthcare Act. As we enter fiscal 2014 we
continue to expect services in Medicare, Medicaid and the private sector to be in demand and
evolving to meet the needs of the new Act.
We began the year with some internal efforts to reduce costs. As these gained traction,
additional efforts were turned toward programs to improve the efficiency of some of our major
services. These efforts were more visibly successful by the end of the year and should continue
to help us in the current year. Although we will continue our vigilance on costs, our effort is now
returning toward investments in the ongoing growth of the Company.
Prior years’ investments in Enterprise Comp created momentum which built throughout the
last year. Margins in this service, negatively impacted by startup costs on new accounts, have
begun to improve. The employer market recognition of CorVel continued to increase. Service
to major insurers continues to be a cornerstone of the Company’s market position. CorVel’s
Pharmacy Benefits Management program (PBM) expanded throughout the year, benefitting
from its interface with our Medical Bill Review services. In addition, clinical modeling of
detailed claims data allows us to intervene when potentially cost driving medication utilization
is identified. Serving as the patients’ advocate, we have been able to introduce our integrated
model, connecting them to more appropriate and effective medical treatment. These services
were introduced last year and began to also grow nicely this year.
Our sights continue to be focused on long-term results, preparing for further future expansion.
Our development team continues as the foundation for our strategic approach to market
opportunities and we are now expanding that investment. We’ve improved our hardware
and communications in preparation for the further expansion of these resources. Software
continues to be our largest area of investment. Our CareMC customer portal has become
ever more utilized and important to our success. We continue to develop mobile computing
applications and to expand our predictive analytic efforts.
The changes in Federal regulation coupled with the ongoing advances in computing technology,
make this a time of significant opportunity. We face these opportunities with the strongest
team of people and technology we’ve yet assembled. We very much appreciate our many
customers who join with us in a spirit of innovation and constant improvement, and thank our
CorVel team for their commitment and effort.
Gordon Clemons
Chairman and CEO
Revenue (in millions)
Annual Revenue Per Q4 Weighted Shares
Earnings Per Share (in dollars)
$400
300
200
100
$0
$60
40
20
$0
95
97
99
01
03
05
07
09
11
13
Stock Price
95
97
99
01
03
05
07
09
11
13
$40
30
20
10
$0
30%
20
10
0%
$2.50
2.00
1.50
1.00
0.50
$0
95
97
99
01
03
05
07
09
11
13
95
97
99
01
03
05
07
09
11
13
Return on Equity (%)
Q4 Weighted Shares (in millions)
24
18
12
6
0
95
97
99
01
03
05
07
09
11
13
95
97
99
01
03
05
07
09
11
13
Corporate Address
CorVel Corporation
2010 Main Street
Suite 600
Irvine, California 92614
Telephone: 888.7.CORVEL
Transfer Agent and Registrar
Computershare Investor Services
Canton, Massachusetts
Counsel
Dorsey & Whitney, LLP
Costa Mesa, California
Independent Auditors
Haskell & White LLP
Irvine, CA
Stock Symbol
The common stock of CorVel
Corporation is traded on the
NASDAQ Global Select Market
under the stock symbol CRVL.
Form 10K
CorVel Corporation Annual Report on Form
10K filed with the Securities and Exchange
Commission may be obtained without charge
by contacting Investor Relations.
Investor Relations
CorVel Corporation
2010 Main Street
Suite 600
Irvine, California 92614
Telephone: 888.7.CORVEL
www.corvel.com/ar2013
investor_relations@corvel.com
Connected Care
Providing healthcare management, patient support and
healthcare financing for patients seeking choice and access.
Our quality and innovative service commitment extends from
every CorVel associate to each customer and patient.
Technology.
Intelligence.
Human Touch.
We apply technology, intelligence and a human
touch to the challenges of risk management so
our clients can intervene early and often while
being connected to the critical intelligence they
need to proactively manage risk.
With a robust technology platform at its core, our
connected solution is delivered by a national team
of associates who are committed to helping clients
deliver programs that meet their organization’s
performance goals.
Our innovative solutions combine claims
management technologies with industry leading
medical cost containment services to meet our
customers’ diverse needs.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
________________
FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended March 31, 2013
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 0-19291
CorVel Corporation
(Exact name of registrant as specified in its charter)
________________
Delaware
(State or other jurisdiction of
incorporation or organization)
2010 Main Street, Suite 600,
Irvine, California
(Address of principal executive offices)
33-0282651
(I.R.S. Employer
Identification Number)
92614
(Zip Code)
Registrant’s telephone number, including area code:
(949) 851-1473
________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
Common Stock
Name of each exchange on which registered:
The NASDAQ Global Select Market, LLC
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act Yes No
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act Yes
No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports)
and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not
be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of
this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of
the Exchange Act. Large accelerated filer
Smaller reporting company
Accelerated filer
Non-accelerated filer
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the
price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of
the Registrant’s most recently completed second fiscal quarter:
As of September 30, 2012, the aggregate market value of the Registrant’s voting and non-voting common equity held by non-
affiliates of the Registrant was approximately $273,360,000 based on the closing price per share of $44.75 for the Registrant’s common
i
stock as reported on the Nasdaq Global Select Market on such date multiplied by 6,108,593 shares (total outstanding shares of
11,238,777 less 5,130,184 shares held by affiliates) of the Registrant’s common stock which were outstanding on such date. For the
purposes of the foregoing calculation only, all of the Registrant’s directors, executive officers and persons known to the Registrant to
hold ten percent or greater of the Registrant’s outstanding common stock have been excluded in that such persons may be deemed to be
affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.
Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latest practicable date: As of
May 28, 2013, there were 10,761,661 shares of the Registrant’s common stock, par value $0.0001 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Information required by Items 10 through 14 of Part III of this Form 10-K, to the extent not set forth herein, is incorporated herein
by reference to portions of the Registrant’s definitive proxy statement for the Registrant’s 2013 Annual Meeting of Stockholders, which
will be filed with the Securities and Exchange Commission not later than 120 days after the end of the fiscal year ended March 31, 2013.
Except with respect to the information specifically incorporated by reference in this Form 10-K, the Registrant’s definitive proxy
statement is not deemed to be filed as a part of this Form 10-K.
ii
CORVEL CORPORATION
2013 FORM 10-K ANNUAL REPORT
TABLE OF CONTENTS
PART I
Page
Item 1.
Business .........................................................................................................................................
2
Item 1A.
Risk Factors ....................................................................................................................................
Item 1B.
Unresolved Staff Comments .........................................................................................................
Item 2.
Properties ........................................................................................................................................
Item 3.
Legal Proceedings ...........................................................................................................................
Item 4.
Mine Safety Disclosures ................................................................................................................
PART II
Item 5.
Item 6.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities ............................................................................................................................
Selected Financial Data ..................................................................................................................
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations .........
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk ........................................................
Item 8.
Financial Statements and Supplementary Data ...............................................................................
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure .........
Item 9A.
Controls and Procedures ...............................................................................................................
Item 9B.
Other Information .........................................................................................................................
PART III
Item 10.
Directors, Executive Officers and Corporate Governance ..............................................................
Item 11.
Executive Compensation ................................................................................................................
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters ............................................................................................................................................
Item 13.
Certain Relationships and Related Transactions, and Director Independence ................................
Item 14.
Principal Accounting Fees and Services .........................................................................................
PART IV
12
18
19
19
20
20
22
23
23
23
23
23
24
24
24
24
25
25
Item 15.
Exhibits, Financial Statement Schedules .......................................................................................
25
Signatures ....................................................................................................................................... 33
iii
In this report, the terms “CorVel”, “Company”, “we”, “us”, and “our” refer to CorVel Corporation and its
subsidiaries.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of the Securities Act of 1933, as
amended, and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including, but not limited to,
the statements about our plans, strategies and prospects under the headings “Business” and “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this report. Words
such as “expects”, “anticipates”, “intends”, “plans”, “predicts”, “believes”, “seeks”, “estimates”, “potential”,
“continue”, “strive”, “ongoing”, “may”, “will”, “would”, “could”, and “should”, and variations of these words or
similar expressions are intended to identify forward-looking statements. These forward-looking statements are based
on management’s current expectations, estimates and projections about our industry, management’s beliefs, and
certain assumptions made by management, and we can give no assurance that we will achieve our plans, intentions
or expectations. Certain important factors could cause actual results to differ materially from the forward-looking
statements we make in this report. Representative examples of these factors include (without limitation):
• General industry and economic conditions;
• Cost of capital and capital requirements;
• Competition from other managed care companies;
• The Company’s ability to renew and/or maintain contracts with its customers on favorable terms or at all;
• The ability to expand certain areas of the Company’s business;
• Possible litigation and legal liability in the course of operations, and the Company’s ability to settle or
otherwise resolve such litigation;
• The ability of the Company to produce market-competitive software;
•
Increases in operating expenses, including employee wages and benefits;
• Changes in regulations affecting the workers’ compensation, insurance and healthcare industries in general;
• The ability to attract and retain key personnel;
• Shifts in customer demands; and
• The availability of financing in the amounts, at the times, and on the terms necessary to support the
Company’s future business.
The section entitled “Risk Factors” set forth in this report discusses these and other important risk factors
that may affect our business, results of operations and financial condition. The factors listed above and the factors
described under the heading “Risk Factors” and similar discussions in our other filings with the Securities and
Exchange Commission are not necessarily all of the important factors that could cause actual results to differ
materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors
also could have material adverse effects on our future results. Investors should consider these factors before
deciding to make or maintain an investment in our securities. The forward-looking statements included in this
annual report on Form 10-K are based on information available to us as of the date of this annual report. We
expressly disclaim any intent or obligation to update any forward-looking statements to reflect subsequent events or
circumstances.
1
Item 1. Business.
INTRODUCTION
PART I
CorVel is a national provider of workers’ compensation solutions for employers, third party administrators,
insurance companies, and government agencies seeking to control costs and promote positive outcomes. The
Company applies technology, intelligence, and a human touch to the challenges of risk management so that their
clients can intervene early and often while being connected to the critical intelligence they need to proactively
manage risk. CorVel specializes in applying advanced communication and information technology to improve
healthcare management for workers’ compensation, group health, auto and liability claims management. With a
robust technology platform at its core, the Company’s connected solution is delivered by a national team of
associates who are committed to helping clients deliver programs that meet their organization’s performance goals.
The Company’s services include claims management, bill review, preferred provider networks, utilization
management, claims management, case management, pharmacy services, directed care and Medicare services.
CorVel offers its services as a bundled solution (i.e. claims management), as a standalone service, or as add-on
services to existing customers. Customers of the Company that do not purchase a bundled solution generally use
another provider, use an in-house solution, or choose not to utilize such a service to manage their workers’
compensation costs. When customers purchase several products from CorVel, the pricing of the products sold is
generally the same as if the product were sold on an individual basis. Bundled products are generally delivered in
the same accounting period.
The Company was incorporated in Delaware in 1987, and its principal executive offices are located at 2010
Main Street, Suite 600, Irvine, California, 92614. The Company’s telephone number is 949-851-1473.
INDUSTRY OVERVIEW
Workers’ compensation is a federally mandated, state-legislated, insurance program that requires
employers to fund medical expenses, lost wages and other costs resulting from work-related injuries and illnesses.
Workers’ compensation benefits and arrangements vary extensively on a state-by-state basis and are often highly
complex. State statutes and court decisions control many aspects of the compensation process, including claims
handling, impairment or disability evaluation, dispute settlement, benefit amount guidelines and cost-control
strategies.
In addition to the compensation process, cost containment and claims management continue to be
significant employer concerns and many look to managed care vendors and third party administrators for cost
savings solutions. The Company believes that cost drivers in workers’ compensation include: implementing
effective return to work and transitional duty programs, coordinating medical care, medical cost management,
recognizing fraud and abuse, and improving communications with injured workers. CorVel provides solutions using
a holistic approach to cost containment and by looking at a complete savings solutions. Often one of the biggest cost
drivers is not recognizing a complex claim at the onset of an injury often resulting in claims being open longer and
resulting in delayed return to work. CorVel uses an integrated claims model that controls claims costs by advocating
medical management at the onset of the injury to decrease administrative costs and to shorten the length of the
disability.
Some states have adopted legislation for managed care organizations (MCO) in an effort to allow
employers to control their worker’s compensation costs. A managed care plan is organized to serve the medical
needs of injured workers in an efficient and cost-effective manner by managing the delivery of medical services
through appropriate health care professionals. CorVel is registered wherever legislation mandates, where it is
beneficial for the Company to obtain a license, or where the MCO is an effective utilized mandate. Since MCO
legislation varies by state, CorVel’s state offerings vary as well. CorVel continually evaluates new legislation to
ensure it is in compliance and can offer services to its customers and prospects.
2
FISCAL 2013 DEVELOPMENTS
Company Stock Repurchase Program
During fiscal 2013, the Company continued to repurchase shares of its common stock under a plan
originally approved by the Company’s Board of Directors in 1996. In February 2012, the Company’s Board of
Directors increased the number of shares authorized to be repurchased over the life of the plan by 1,000,000 shares
to 16,000,000 shares. During fiscal 2013, the Company spent $30.7 million to repurchase 705,406 shares of its
common stock. Since commencing this program in the fall of 1996, the Company has repurchased 15,658,507 shares
of its common stock through March 31, 2013, at a cost of $301 million. These repurchases were funded primarily
from the Company’s operating cash flows.
BUSINESS— SERVICES
The Company offers services in two general categories, network solutions and patient management, to
assist its customers in managing the increasing medical costs of workers’ compensation, group health and auto
insurance, and monitoring the quality of care provided to claimants. CorVel reduces claims costs by advocating
medical management at the onset of an injury to decrease administrative costs and to shorten the length of the
disability. These solutions offer personalized treatment programs that use precise treatment protocols to advocate
timely, quality care for injured workers.
Network Solutions
CorVel offers a complete medical savings solution for all in-network and out-of-network medical bills
including PPO management, medical bill repricing, true line item review, professional nurse review and automated
adjudication. Each feature focuses on maximizing savings opportunities and increasing efficiencies.
Bill Review
Many states have adopted fee schedules, which regulate the maximum allowable fees payable under
workers’ compensation, for procedures performed by a variety of health treatment providers. Developed in 1989,
CorVel’s proprietary bill review and claims management technology automates the review process to provide
customers with a faster turnaround time, more efficient bill review and a higher total savings. CorVel’s artificial
intelligence engine includes over ten million individual rules, which creates a comprehensive review process and
greater efficiencies than traditional bill review services.
Payors are able to review and approve bills online as well as access savings reports through an online
portal, CareMC. The process is paperless, through scanning and electronic data interface (“EDI”), while proving to
be cost effective and efficient. CorVel’s solutions are fully customizable and can be tailored to meet unique payor
requirements.
Bill Review Services include:
• Coding review and rebundling
• Reasonable and customary review
• Fee schedule analysis
• Out-of-network bill review
• Pharmacy review
• PPO management
• Repricing
3
PPO Management
PPOs are groups of hospitals, physicians and other healthcare providers that offer services at pre-negotiated
rates to employee groups. The Company believes that PPO networks offer the employer an additional means of
managing healthcare costs by reducing the per-unit price of medical services provided to employees. CorVel began
offering a proprietary national PPO network in 1992 and today it is comprised of over 750,000 board certified
providers. The Company provides the convenience of a PPO Provider look-up mobile application for use with
iPhone, iPad and Android. The application is available to the public and makes it convenient to locate a provider in
the CorVel network. Users can search providers based on current location and by specialty.
CorVel has a long-term strategy of network development, providing comprehensive networks to our
customers and customization of networks to meet the specific needs of our customers. The Company believes that
the combination of its national PPO director’s strength and presence and the local PPO developers’ commitment and
community involvement enables CorVel to build, support and strengthen its PPO in size, quality, depth of discount,
and commitment to service.
The Company has a team of national, regional and local personnel supporting the CorVel network. This
team includes a national PPO manager in addition to locally based PPO developers who are responsible for local
recruitment, contract negotiations, credentialing and re-credentialing of providers, and working with customers to
develop customer specific provider networks. Each bill review unit has provider relations support staff to address
provider grievances and other billing issues.
Providers are selected from criteria based on quality, range of services, price and location. Each provider is
thoroughly evaluated and credentialed, then re-credentialed every three years. Through this extensive evaluation
process, we believe the PPO networks are able to provide significant hospital, physician and ancillary medical
savings, while striving to maintain high quality care. Provider network services include a national network for all
medical coverages, board certified physicians, provider credentialing, patient channeling, online PPO look-up,
printable directories and driving directions, and Managed Care Organizations (MCO).
Enhanced Bill Review
CorVel’s enhanced bill review program allows claim payors to adjust individual line item charges on all
bills to reasonable and customary levels while removing all error and billing discrepancies with professional review.
The enhanced bill review program scrutinizes each hospital line description and charge as a separate and distinct
claim for reimbursement. CorVel’s proprietary Universal Chargemaster defines each code and description, enabling
its registered nurses to identify errors, duplicate charges, re-bundle exploded charges, correct quantity discrepancies
and remove unused supplies.
Professional Review
CorVel’s services offer a complete audit and validation of facility bill accuracy. This solution also includes
review of in-network facility bills. The Company’s nurse auditors have clinical backgrounds in all areas of
medicine, medical billing and coding to ensure an accurate, consistent and thorough review. If a bill is identified for
professional review, the bill image and its associated medical reports are routed within the system to an experienced
medical nurse for review and auditing.
Provider Reimbursement
Through the bill review system, CorVel has the capability to provide check writing or provider
reimbursement services for its customers. The provider payment check can be added to the bill analysis to produce
one combined document.
4
Pharmacy Services
CorVel provides patients with a full-feature pharmacy program that offers discounted prescriptions, drug
interaction monitoring and eligibility confirmation. Our pharmacy network of nationally recognized pharmacies
provides savings off the retail price of prescriptions associated with a workers’ compensation claim. The Company’s
pharmacy services program includes preferred access to a national pharmacy network, streamlined processing for
pharmacies at point of sale, mail order, 90-day retail, out of network, medication review services and clinical
modeling.
Directed Care Services
CorVel has contracted with medical imaging, physical therapy and ancillary service networks to offer
convenient access, timely appointments and preferred rates for these services. The Company manages the entire
coordination of care from appointment scheduling through reimbursement, working to achieve timely recovery and
increased savings. The Company has directed care networks for diagnostic imaging, physical and occupational
therapy, independent medical evaluations, durable medical equipment and transportation and translation.
Medicare Solutions
The Company offers solutions to help manage the requirements mandated by the Centers for Medicare and
Medicaid Services (CMS). Services include Medicare Set Asides and a new service, Agent Reporting Services, to
help employers comply with new CMS reporting legislation. As an assigned agent, CorVel can provide services for
Responsible Reporting Entities (RRE) such as insurers and employers. As an experienced information-processing
provider, CorVel is able to electronically submit files to the CMS in compliance with timelines and reporting
requirements.
Clearinghouse Services
CorVel’s proprietary medical review software and claims management technology interfaces with multiple
clearinghouses. The Company’s clearinghouse services provides for medical review, conversion of electronic forms
to appropriate payment formats, seamless submittal of bills for payments and rules engines used to help ensure
jurisdictional compliance.
Patient Management
CorVel offers a unique approach to claims administration and patient management. This integrated service
model controls claims by advocating medical management at the onset of the injury to decrease administrative costs
and to shorten the length of the disability. The Company offers these services on a stand-alone basis or as an
integrated component of its medical cost containment services.
Claims Management
CorVel has been a third party administrator (“TPA”) offering claims management services since January
2007. The Company serves customers in the self-insured or commercially insured markets. Incidents and injuries are
reported through a variety of intake methods that include mobile applications, toll-free call centers and traditional
methods of paper and fax reporting. They are immediately processed by CorVel’s proprietary rules engine, which
provides alerts and recommendations throughout the life of a claim. This technology instantly assigns an expert
claims professional, while simultaneously determining if a claim requires any immediate attention for triage.
Through this service, the Company serves clients in the self-insured or commercially insured market
through alternative loss funding methods, and provides them with a complete range of services, including claims
administration, case management, and medical bill review. In addition to the field investigation and evaluation of
claims, the Company also may provide initial loss reporting services for claims, loss mitigation services such as
medical bill review and vocational rehabilitation, administration of trust funds established to pay claims and risk
management information services.
5
Some of the features of claims management services include: automated first notice of loss, three-point
contact within 24 hours, prompt claims investigations, detailed diary notes for each step of the claim, graphical
dashboards and claim history scorecards, and litigation management and expert testimony.
Case Management
CorVel’s case management and utilization review services address all aspects of disability management and
recovery including utilization review (pre-certification, concurrent review and discharge planning), early
intervention, telephonic, field and catastrophic case management as well as vocational rehabilitation.
The medical management components of CorVel’s program focus on medical intervention, management
and appropriateness. In these cases, the Company’s case managers confer with the attending physician, other
providers, the patient and the patient’s family to identify the appropriate rehabilitative treatment and most cost-
effective healthcare alternatives. The program is designed to offer the injured party prompt access to appropriate
medical providers who will provide quality cost-effective medical care. Case managers may coordinate the services
or care required and may arrange for special pricing of the required services.
The Telephonic Case Manager (TCM) continues to impact the direction of the case, focusing on early
return to work, maximum medical improvement (MMI) and appropriate duration of disability. Facilitation of
appropriate treatment, assertive negotiation with medical providers and directing the care of the injured worker
continues to be the Case Manager’s role until the closure criteria is met. Utilization review of provider treatment
remains ongoing until discharge from treatment.
In the event that a claim may require an onsite referral, a Field Case Manager (FCM) will be assigned to the
claim. Cases can be referred to CorVel based on geographic location and injury type to the most appropriate FCM.
Specialized case management services include catastrophic management, life care planning, and vocational
rehabilitation services. All FCMs have iPads that provides access to the Company’s proprietary mobile app that
provides instant access to detailed case information and to enter case notes.
24/7 Nurse Triage
Injured workers can call at the time of injury or incident and speak with a nurse who specializes in
occupational injuries. An assessment is immediately made to recommend self-care, or referral for further medical
care if needed. CorVel is able to provide quick and accurate care intervention, often preventing a minor injury from
becoming an expensive claim. The 24/7 nurse triage services provides channeling to a preferred network of
providers, allows employer access to online case information, comprehensive incident gathering, and healthcare
advocacy for injured workers.
Utilization Management
Utilization Management programs review proposed ambulatory care to determine appropriateness,
frequency, duration and setting. These programs utilize experienced registered nurses, proprietary medical treatment
protocols and systems technology to avoid unnecessary treatments and associated costs. Processes in Utilization
Management include: injury review, diagnosis and treatment planning; contacting and negotiating provider
treatment requirements; certifying appropriateness of treatment parameters, and responding to provider requests for
additional treatment. Utilization management services include: prospective review, retrospective review, concurrent
review, second opinion, peer review and independent medical evaluation.
Vocational Rehabilitation
CorVel’s Vocational Rehabilitation program is designed for injured workers needing assistance returning to
work or retaining employment. This comprehensive suite of services helps employees who are unable to perform
previous work functions and who faces the possibility joining the open labor market to seek re-employment. These
services are available unbundled, on an integrated basis as dictated by the requirement of each case and client
preference, or by individual statutory requirements. Vocational rehabilitation services include ergonomic
6
assessments, rehabilitation plans, transferable skills analysis, labor market services, resume’-development, job
analysis and development, job placement, and expert testimony.
Life Care Planning
Life Care Planning is used to project long-term future needs, services and related costs associated with
catastrophic injury. CorVel’s Life Care Plans summarize extensive amounts of medical data and compile it into a
comprehensive report for future care requirements, aiding improved outcomes and timely resolution of claims. Some
of the features of the Company’s Life Care Planning services include: comprehensive documentation, projecting
future care requirements, customized reporting, and costs specific to local areas.
Disability Management
CorVel’s disability management programs offer a continuum of services for short and long-term disability
coverages that advocate an employee’s early return to work. Disability management services include absence
reporting, disability evaluations, national preferred provider organizations, independent medical examinations,
utilization review, medical case management, return to work coordination and integrated reporting.
Liability Claims Management
CorVel also offers liability claims management services that can be sold as a stand-alone service or part of
patient management. The Company’s services include auto liability, general liability, product liability, personal
injury, professional liability and property damage, accidents and weather-related damage. This service includes
claims management, adjusting services, litigation management, claims subrogation, and investigations.
Auto Claims Management
Injury claims are one of the largest components of auto indemnity costs. Effective management of these
claims and their associated costs, combined with an optimal healthcare management program, helps CorVel’s
customers reduce claim costs. The Company’s auto claims services include national preferred provider organization,
medical bill review, first and third party bill review, first notice of loss, demand packet reviews and reporting and
analytics.
SYSTEMS AND TECHNOLOGY
Infrastructure and Data Center
The Company utilizes a Tier III-rated data center as its primary processing site. Redundancy is provided at
many levels in power, cooling, and computing resources, with the goal of ensuring maximum uptime and system
availability for the Company’s production systems. The Company has also begun to implement use of server
virtualization and consolidation techniques to push the fault-tolerance of systems even further. These technologies
bring increased speed-to-production and scalability.
Adoption of Imaging Technologies and Paperless Workflow
Utilizing scanning and automated data capture processes allows the Company to process incoming paper
and electronic claims documents, including medical bills, with less manual handling and which has improved the
Company’s workflow processes. This has benefitted both the Company, in terms of cost-savings, and the
Company’s customers, in improved savings results. Through the Company’s internet portal, www.caremc.com,
customers can review the bills as soon as they are processed and approve a bill for payment, streamlining the
customer’s own workflows and expediting the payment process.
Redundancy Center
The Company’s national data center is located near Portland, Oregon. The Company also has a redundancy
center located in Ft.Worth, Texas. The redundancy center is the Company’s backup processing site in the event that
7
the Portland data center suffers catastrophic loss. Currently, the Company’s data is continually replicated to Ft.
Worth in near-real time, so that in the event the Portland data center is offline, the redundancy center can be
activated with current information quickly. The Ft. Worth data center also hosts duplicates of the Company’s
Websites. The Ft.Worth systems are maintained and exercised on a continuous basis as they host demonstration and
pilot environments that mirror production, with the goal of ensuring their ongoing readiness.
CareMC
CareMC (www.caremc.com) has become the application platform for all of the Company’s primary service
lines and delivers immediate access to customers. CareMC offers customers direct access to the Company’s primary
services. CareMC allows for electronic communication and reporting between providers, payers, employers and
patients. Features of the website include: report an incident/injury, request for service, appointment scheduling,
online bill review, claims information management, treatment calendar, medical bill adjudication and automated
provider reimbursement.
Through the CareMC Website, users can:
• request services online;
• manage files throughout the life of the claim;
• receive and relay case notes from case managers; and
• integrate information from multiple claims management sources into one database.
The CareMC website facilitates healthcare transaction processing. Using artificial intelligence techniques,
the website provides situation alerts and event triggers, to facilitate prompt and effective decisions. Users of
CareMC can quickly see where event outliers are occurring within the claims management process. If costs exceed
pre-determined thresholds or activities fall outside expected timelines, decision-makers can be quickly notified.
Large amounts of information are consolidated and summarized to help customers focus on the critical issues.
Scanning Services
We continue to leverage our scanning technologies which include scanning, optical character recognition
and document management services. We continue to expand our existing office automation service line and all
offices are selling scanning and document management. We have added scanning operations to most of the
Company’s larger offices around the country, designating them “Capture Centers.” Our scanning service also offers
a web interface (www.onlinedocumentcenter.com) providing immediate access to documents and data called the
Online Document Center (ODC). Secure document review, approval, transaction workflow and archival storage are
available at subscription-based pricing.
Claims Processing
We continue to develop our claims system capabilities which fit well with the Company’s preference for
owning and maintaining our own software assets. Integration projects, some already completed, are underway to
present more of this claims-centric information available through the CareMC web portal. The Company’s goal is to
continue to modernize user interfaces, and to streamline the delivery of this information to our customers, giving
more rapid feedback and putting real-time information in the hands of our customers.
INDUSTRY, CUSTOMERS AND MARKETING
CorVel serves a diverse group of customers that include insurers, third party administrators, self-
administered employers, government agencies, municipalities, state funds, and numerous other industries. CorVel is
able to provide workers’ compensation services to virtually any size employer and in any state or region of the
United States. No single customer of the Company represented more than 10% of revenues in fiscal 2011, 2012, or
2013. Many claims management decisions in workers’ compensation are the responsibility of the local claims office
of national or regional insurers. The Company’s national branch office network enables the Company to market and
8
offer its services at both a local and national account level. The Company is placing increasing emphasis on national
account marketing. The sales and marketing activities of the Company are conducted primarily by account
executives located in key geographic areas.
COMPETITION AND MARKET CONDITIONS
The healthcare cost containment industry is competitive and is subject to economic pressures for cost
savings and legislative reforms. CorVel’s primary competitors in the workers’ compensation market include third
party administrators, managed care companies, large insurance carriers and numerous independent companies. Many
of the Company’s competitors are significantly larger and have greater financial and marketing resources than the
Company. Moreover, the Company’s customers may establish the in-house capability of performing services offered
by the Company. If the Company is unable to compete effectively, it will be difficult for the Company to add and
retain customers, and the Company’s business, financial condition and results of operations will be materially and
adversely affected.
The past few years have seen acceleration in the technology world, and advancements seem to be progressing at a
pace that few, if any, have ever witnessed. The proliferation of smart phones and tablet computers allows the
Company’s clients to stay connected at any time, from anywhere. This capability provides immediate access and
begins to present business opportunities that were previously predicated on a less connected environment. The
Company continues to leverage the new wave of technology in order to connect all of the parties involved in the
workers' compensation process in ways that were unimaginable in the past. As with general health, the workers
compensation line continues to migrate to being a medical management business, with policymakers, employers,
and carriers struggling to manage and control the costs of medical care (Source” National Council on Compensation
Insurance), the Company will continue to focus the execution of its strategy to provide industry leading claims
management and cost containment solutions to the market.
GOVERNMENT REGULATIONS
General
Managed healthcare programs for workers’ compensation are subject to various laws and regulations. Both
the nature and degree of applicable government regulation vary greatly depending upon the specific activities
involved. Generally, parties that actually provide or arrange for the provision of healthcare services, assume
financial risk related to the provision of those services or undertake direct responsibility for making payment or
payment decisions for those services. These parties are subject to a number of complex regulatory requirements that
govern many aspects of their conduct and operations.
In contrast, the management and information services provided by the Company to its customers typically
have not been the subject of regulation by the federal government or the states. Since the managed healthcare field is
a rapidly expanding and changing industry and the cost of providing healthcare continues to increase, it is possible
that the applicable state and federal regulatory frameworks will expand to have a greater impact upon the conduct
and operation of the Company’s business.
Under the current workers’ compensation system, employer insurance or self-funded coverage is governed
by individual laws in each of the 50 states and by certain federal laws. The management and information services
that make up the Company’s managed care program serve markets that have developed largely in response to needs
of insurers, employers and large TPAs, and generally have not been mandated by legislation or other government
action. On the other hand, the vocational rehabilitation case management marketplace within the workers’
compensation system has been dependent upon the laws and regulations within those states that require the
availability of specified rehabilitation services for injured workers. Similarly, the Company’s fee schedule auditing
services address market needs created by certain states’ enactment of maximum permissible fee schedules for
workers’ compensation services. Changes in individual state regulation of workers’ compensation may create a
greater or lesser demand for some or all of the Company’s services or require the Company to develop new or
modified services in order to meet the needs of the marketplace and compete effectively in that marketplace.
9
Medical Cost Containment Legislation
Historically, governmental strategies to contain medical costs in the workers’ compensation field have been
generally limited to legislation on a state-by-state basis. For example, many states have implemented fee schedules
that list maximum reimbursement levels for healthcare procedures. In certain states that have not authorized the use
of a fee schedule, the Company adjusts bills to the usual and customary levels authorized by the payor.
Opportunities for the Company’s services could increase if more states legislate additional cost containment
strategies. Conversely, the Company would be materially and adversely affected if states elect to reduce the extent
of medical cost containment strategies available to insurance carriers and other payors, or adopt other strategies for
cost containment that would not support a demand for the Company’s services.
Healthcare Reform
There has been considerable discussion of healthcare reform at both the federal level and in numerous state
legislatures in recent years. Due to uncertainties regarding the ultimate features of reform initiatives and the timing
of their enactment, the Company cannot predict which, if any, reforms will be adopted, when they may be adopted,
or what impact they may have on the Company. The Company is still evaluating the impact of the health reform
legislation which was enacted by Congress in March 2010 on the future results and costs of the Company. The
Company does not anticipate that this legislation will have a material impact on the Company’s revenue. The
legislation could increase the Company’s future healthcare benefit costs.
SHAREHOLDER RIGHTS PLAN
During fiscal 1997, the Company’s Board of Directors approved the adoption of a Shareholder Rights Plan.
The Shareholder Rights Plan provides for a dividend distribution to CorVel stockholders of one preferred stock
purchase right for each outstanding share of CorVel’s common stock under certain circumstances. In April 2002,
the Board of Directors of CorVel approved an amendment to the Shareholder Rights Plan to extend the expiration
date of the rights to February 10, 2012, set the exercise price of each right at $118, and enable Fidelity Management
& Research Company and its affiliates to purchase up to 18% of the shares of common stock of the Company
without triggering the stockholder rights, with the limitations under the Shareholder Rights Plan remaining in effect
for all other stockholders of the Company. In November 2008, the Company’s Board of Directors approved an
amendment to the Shareholder Rights Plan to extend the expiration date of the rights to February 10, 2022, remove
the ability of Fidelity Management & Research Company and its affiliates to purchase up to 18% of the shares of
common stock of the Company without triggering the stockholder rights, substitute Computershare Trust Company,
N.A. as the rights agent and effect certain technical changes to the Shareholder Rights Plan.
The rights are designed to assure that all shareholders receive fair and equal treatment in the event of any
proposed takeover of the Company and to encourage a potential acquirer to negotiate with the Board of Directors
prior to attempting a takeover. The rights have an exercise price of $118 per right, subject to subsequent adjustment.
The rights trade with the Company’s common stock and will not be exercisable until the occurrence of certain
takeover-related events.
Generally, the Shareholder Rights Plan provides that if a person or group acquires 15% or more of the
Company’s common stock without the approval of the Board, subject to certain exception, the holders of the rights,
other than the acquiring person or group, would, under certain circumstances, have the right to purchase additional
shares of the Company’s common stock having a market value equal to two times the then-current exercise price of
the right.
In addition, if the Company is thereafter merged into another entity, or if 50% or more of the Company’s
consolidated assets or earning power are sold, then the right will entitle its holder to buy common shares of the
acquiring entity having a market value equal to two times the then-current exercise price of the right. The
Company’s Board of Directors may exchange or redeem the rights under certain conditions.
10
EMPLOYEES
As of March 31, 2013, CorVel had 3,172 employees, including nurses, therapists, counselors and other
employees. No employees are represented by any collective bargaining unit. Management believes the Company’s
relationship with its employees to be good.
AVAILABLE INFORMATION
Copies of our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form
8-K, and amendments to those reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities
Exchange Act of 1934, and other filings made with the Securities and Exchange Commission, are available free of
charge through our Web site (http://www.corvel.com, under the Investor section) as soon as reasonably practicable
after such reports are electronically filed with, or furnished to, the Securities and Exchange Commission. The
inclusion of our Web site address and the address of any of our portals, such as www.caremc.com and
www.onlinedocumentcenter.com, in this report does not include or incorporate by reference into this report any
information contained on, or accessible through, such Web sites.
11
Item 1A. Risk Factors.
Past financial performance is not necessarily a reliable indicator of future performance, and investors in our
common stock should not use historical performance to anticipate results or future period trends. Investing in our
common stock involves a high degree of risk. Investors should consider carefully the following risk factors, as well
as the other information in this report and our other filings with the Securities and Exchange Commission, including
our consolidated financial statements and the related notes, before deciding whether to invest or maintain an
investment in shares of our common stock. If any of the following risks actually occurs, our business, financial
condition and results of operations would suffer. In this case, the trading price of our common stock would likely
decline. The risks described below are not the only ones we face. Additional risks that we currently do not know
about or that we currently believe to be immaterial also may impair our business operations.
If we fail to grow our business internally or through strategic acquisitions we may be unable to execute our
business plan, maintain high levels of service or adequately address competitive challenges.
Our strategy is to continue internal growth and, as strategic opportunities arise in the workers’
compensation managed care industry, to consider acquisitions of, or relationships with, other companies in related
lines of business. As a result, we are subject to certain growth-related risks, including the risk that we will be unable
to retain personnel or acquire other resources necessary to service such growth adequately. Expenses arising from
our efforts to increase our market penetration may have a negative impact on operating results. In addition, there can
be no assurance that any suitable opportunities for strategic acquisitions or relationships will arise or, if they do
arise, that the transactions contemplated could be completed. If such a transaction does occur, there can be no
assurance that we will be able to integrate effectively any acquired business. In addition, any such transaction would
be subject to various risks associated with the acquisition of businesses, including, but not limited to, the following:
• an acquisition may negatively impact our results of operations because it may require incurring large one-
time charges, substantial debt or liabilities; it may require the amortization or write down of amounts related
to deferred compensation, goodwill and other intangible assets; or it may cause adverse tax consequences,
substantial depreciation or deferred compensation charges;
• we may encounter difficulties in assimilating and integrating the business, technologies, products, services,
personnel or operations of companies that are acquired, particularly if key personnel of the acquired company
decide not to work for us;
• an acquisition may disrupt ongoing business, divert resources, increase expenses and distract management;
• the acquired businesses, products, services or technologies may not generate sufficient revenue to offset
acquisition costs;
• we may have to issue equity or debt securities to complete an acquisition, which would dilute the position of
stockholders and could adversely affect the market price of our common stock; and
• acquisitions may involve the entry into a geographic or business market in which we have little or no prior
experience.
There can be no assurance that we will be able to identify or consummate any future acquisitions or other
strategic relationships on favorable terms, or at all, or that any future acquisition or other strategic relationship will
not have an adverse impact on our business or results of operations. If suitable opportunities arise, we may finance
such transactions, as well as internal growth, through debt or equity financing. There can be no assurance, however,
that such debt or equity financing would be available to us on acceptable terms when, and if, suitable strategic
opportunities arise.
If we are unable to increase our market share among national and regional insurance carriers and large, self-
funded employers, our results may be adversely affected.
12
Our business strategy and future success depend in part on our ability to capture market share with our cost
containment services as national and regional insurance carriers and large, self-funded employers look for ways to
achieve cost savings. We cannot assure you that we will successfully market our services to these insurance carriers
and employers or that they will not resort to other means to achieve cost savings. Additionally, our ability to capture
additional market share may be adversely affected by the decision of potential customers to perform services
internally instead of outsourcing the provision of such services to us. Furthermore, we may not be able to
demonstrate sufficient cost savings to potential or current customers to induce them not to provide comparable
services internally or to accelerate efforts to provide such services internally.
If competition increases, our growth and profits may decline.
The markets for our network services and patient management services are also fragmented and
competitive. Our competitors include national managed care providers, preferred provider networks, smaller
independent providers and insurance companies. Companies that offer one or more workers’ compensation managed
care services on a national basis are our primary competitors. We also compete with many smaller vendors who
generally provide unbundled services on a local level, particularly companies with an established relationship with a
local insurance company adjuster. In addition, several large workers’ compensation insurance carriers offer managed
care services for their customers, either by performance of the services in-house or by outsourcing to organizations
like ours. If these carriers increase their performance of these services in-house, our business may be adversely
affected. In addition, consolidation in the industry may result in carriers performing more of such services in-house.
Our sequential revenue may not increase and may decline. As a result, we may fail to meet or exceed the
expectations of investors or analysts which could cause our common stock price to decline.
Our sequential revenue growth may not increase and may decline in the future as a result of a variety of
factors, many of which are outside of our control. If changes in our sequential revenue fall below the expectations of
investors or analysts, the price of our common stock could decline substantially. Fluctuations or declines in
sequential revenue growth may be due to a number of factors, including, but not limited to, those listed below and
identified throughout this “Risk Factors” section: the decline in manufacturing employment, the decline in workers’
compensation claims, the decline in healthcare expenditures, the considerable price competition in a flat-to-declining
workers’ compensation market, litigation, the increase in competition, and the changes and the potential changes in
state workers’ compensation and automobile managed care laws which can reduce demand for our services. These
factors create an environment where revenue and margin growth is more difficult to attain and where revenue
growth is less certain than historically experienced. Additionally, our technology and preferred provider network
face competition from companies that have more resources available to them than we do. Also, some customers may
handle their managed care services in-house and may reduce the amount of services which are outsourced to
managed care companies such as CorVel. These factors could cause the market price of our common stock to
fluctuate substantially. There can be no assurance that our growth rate in the future, if any, will be at or near
historical levels.
In addition, the stock market has in the past experienced price and volume fluctuations that have
particularly affected companies in the healthcare and managed care markets resulting in changes in the market price
of the stock of many companies, which may not have been directly related to the operating performance of those
companies
Due to the foregoing factors, and the other risks discussed in this report, investors should not rely on
period-to-period comparisons of our results of operations as an indication of our future performance.
If the referrals for our patient management services decline, our business, financial condition and results of
operations would be materially adversely affected.
In some years, we have experienced a general decline in the revenue and operating performance of patient
management services. We believe that the performance decline has been due to the following factors: the decrease
of the number of workplace injuries that have become longer-term disability cases; increased regional and local
competition from providers of managed care services; a possible reduction by insurers on the types of services
provided by our patient management business; the closure of offices and continuing consolidation of our patient
13
management operations; and employee turnover, including management personnel, in our patient management
business. In the past, these factors have all contributed to the lowering of our long-term outlook for our patient
management services. If some or all of these conditions continue, we believe that the performance of our patient
management revenues could decrease.
Declines in workers’ compensation claims may harm our results of operations.
Within the past few years, the economy has performed below historical averages which leads to fewer
workers on a national level and could lead to fewer work related injuries. If declines in workers’ compensation costs
occur in many states and persist over the long-term, it would have an adverse impact on our business, financial
condition and results of operations.
We provide an outsource service to payors of workers’ compensation and auto healthcare benefits. These
payors include insurance companies, TPAs, municipalities, state funds, and self-insured, self-administered
employers. If these payors reduce the amount of work they outsource, our results of operations would be materially
adversely affected.
Healthcare providers are becoming increasingly resistant to the application of certain healthcare cost
containment techniques; this may cause revenue from our cost containment operations to decrease.
Healthcare providers have become more active in their efforts to minimize the use of certain cost
containment techniques and are engaging in litigation to avoid application of certain cost containment practices.
Recent litigation between healthcare providers and insurers has challenged certain insurers’ claims adjudication and
reimbursement decisions. Although these lawsuits do not directly involve us or any services we provide, these cases
may affect the use by insurers of certain cost containment services that we provide and may result in a decrease in
revenue from our cost containment business.
Our failure to compete successfully could make it difficult for us to add and retain customers and could reduce or
impede the growth of our business.
We face competition from PPOs, TPAs and other managed healthcare companies. We believe that as
managed care techniques continue to gain acceptance in the workers’ compensation marketplace, our competitors
will increasingly consist of nationally-focused workers’ compensation managed care service companies, insurance
companies, HMOs and other significant providers of managed care products. Legislative reform in some states has
been considered, but not enacted to permit employers to designate health plans such as HMOs and PPOs to cover
workers’ compensation claimants. Because many health plans have the ability to manage medical costs for workers’
compensation claimants, such legislation may intensify competition in the markets served by us. Many of our
current and potential competitors are significantly larger and have greater financial and marketing resources than we
do, and there can be no assurance that we will continue to maintain our existing customers, our past level of
operating performance or be successful with any new products or in any new geographical markets we may enter.
A breach of security may cause our customers to curtail or stop using our services.
We rely largely on our own security systems, confidentiality procedures and employee nondisclosure
agreements to maintain the privacy and security of our and our customers’ proprietary information. Accidental or
willful security breaches or other unauthorized access by third parties to our information systems, the existence of
computer viruses in our data or software and misappropriation of our proprietary information could expose us to a
risk of information loss, litigation and other possible liabilities which may have a material adverse effect on our
business, financial condition and results of operations. If security measures are breached because of third-party
action, employee error, malfeasance or otherwise, or if design flaws in our software are exposed and exploited, and,
as a result, a third party obtains unauthorized access to any customer data, our relationships with our customers and
our reputation will be damaged, our business may suffer and we could incur significant liability. Because techniques
used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until
launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative
measures.
14
Exposure to possible litigation and legal liability may adversely affect our business, financial condition and
results of operations.
We, through our utilization management services, make recommendations concerning the appropriateness
of providers’ medical treatment plans of patients throughout the country, and as a result, could be exposed to claims
for adverse medical consequences. We do not grant or deny claims for payment of benefits and we do not believe
that we engage in the practice of medicine or the delivery of medical services. There can be no assurance, however,
that we will not be subject to claims or litigation related to the authorization or denial of claims for payment of
benefits or allegations that we engage in the practice of medicine or the delivery of medical services.
In addition, there can be no assurance that we will not be subject to other litigation that may adversely
affect our business, financial condition or results of operations, including but not limited to being joined in litigation
brought against our customers in the managed care industry. We maintain professional liability insurance and such
other coverages as we believe are reasonable in light of our experience to date. If such insurance is insufficient or
unavailable in the future at reasonable cost to protect us from liability, our business, financial condition or results of
operations could be adversely affected.
If the utilization by healthcare payors of early intervention services continues to increase, the revenue from our
later-stage network and healthcare management services could be negatively affected.
The performance of early intervention services, including injury occupational healthcare, first notice of
loss, and telephonic case management services, often result in a decrease in the average length of, and the total costs
associated with, a healthcare claim. By successfully intervening at an early stage in a claim, the need for additional
cost containment services for that claim often can be reduced or even eliminated. As healthcare payors continue to
increase their utilization of early intervention services, the revenue from our later stage network and healthcare
management services will decrease.
An interruption in our ability to access critical data may cause customers to cancel their service and/or may
reduce our ability to effectively compete.
Certain aspects of our business are dependent upon our ability to store, retrieve, process and manage data
and to maintain and upgrade our data processing capabilities. Interruption of data processing capabilities for any
extended length of time, loss of stored data, programming errors or other system failures could cause customers to
cancel their service and could have a material adverse effect on our business and results of operations.
In addition, we expect that a considerable amount of our future growth will depend on our ability to process
and manage claims data more efficiently and to provide more meaningful healthcare information to customers and
payors of healthcare. There can be no assurance that our current data processing capabilities will be adequate for our
future growth, that we will be able to efficiently upgrade our systems to meet future demands, or that we will be able
to develop, license or otherwise acquire software to address these market demands as well or as timely as our
competitors.
We face competition for staffing, which may increase our labor costs and reduce profitability.
We compete with other healthcare providers in recruiting qualified management and staff personnel for the
day-to-day operations of our business, including nurses and other case management professionals. In some markets,
the scarcity of nurses and other medical support personnel has become a significant operating issue to healthcare
providers. This shortage may require us to enhance wages to recruit and retain qualified nurses and other healthcare
professionals. Our failure to recruit and retain qualified management, nurses and other healthcare professionals, or to
control labor costs could have a material adverse effect on profitability.
The increased costs of professional and general liability insurance may have an adverse effect on our
profitability.
15
The cost of commercial professional and general liability insurance coverage has risen significantly in the
past several years, and this trend may continue. In addition, if we were to suffer a material loss, our costs may
increase over and above the general increases in the industry. If the costs associated with insuring our business
continue to increase, it may adversely affect our business. We believe our current level of insurance coverage is
adequate for a company of our size engaged in our business.
If lawsuits against us are successful, we may incur significant liabilities.
We provide to insurers and other payors of healthcare costs managed care programs that utilize preferred
provider organizations and computerized bill review programs. Health care providers have brought, against us and
our customers, individual and class action lawsuits challenging such programs. If such lawsuits are successful, we
may incur significant liabilities.
We make recommendations about the appropriateness of providers’ proposed medical treatment plans for
patients throughout the country. As a result, we could be subject to claims arising from any adverse medical
consequences. Although plaintiffs have not to date subjected us to any claims or litigation relating to the granting or
denial of claims for payment of benefits or allegations that we engage in the practice of medicine or the delivery of
medical services, we cannot assure you that plaintiffs will not make such claims in future litigation. We also cannot
assure you that our insurance will provide sufficient coverage or that insurance companies will make insurance
available at a reasonable cost to protect us from significant future liability.
Changes in government regulations could increase our costs of operations and/or reduce the demand for our
services.
Many states, including a number of those in which we transact business, have licensing and other
regulatory requirements applicable to our business. Approximately half of the states have enacted laws that require
licensing of businesses which provide medical review services such as ours. Some of these laws apply to medical
review of care covered by workers’ compensation. These laws typically establish minimum standards for
qualifications of personnel, confidentiality, internal quality control and dispute resolution procedures. These
regulatory programs may result in increased costs of operation for us, which may have an adverse impact upon our
ability to compete with other available alternatives for healthcare cost control. In addition, new laws regulating the
operation of managed care provider networks have been adopted by a number of states. These laws may apply to
managed care provider networks having contracts with us or to provider networks which we may organize. To the
extent we are governed by these regulations, we may be subject to additional licensing requirements, financial and
operational oversight and procedural standards for beneficiaries and providers.
Regulation in the healthcare and workers’ compensation fields is constantly evolving. We are unable to
predict what additional government initiatives, if any, affecting our business may be promulgated in the future. Our
business may be adversely affected by failure to comply with existing laws and regulations, failure to obtain
necessary licenses and government approvals or failure to adapt to new or modified regulatory requirements.
Proposals for healthcare legislative reforms are regularly considered at the federal and state levels. To the extent that
such proposals affect workers’ compensation, such proposals may adversely affect our business, financial condition
and results of operations.
In addition, changes in workers’ compensation, auto and managed health care laws or regulations may
reduce demand for our services, require us to develop new or modified services to meet the demands of the
marketplace or reduce the fees that we may charge for our services. One proposal which had been considered in the
past, but not enacted by Congress or certain state legislatures, is 24-hour health coverage, in which the coverage of
traditional employer-sponsored health plans is combined with workers’ compensation coverage to provide a single
insurance plan for work-related and non-work-related health problems.
The introduction of software products incorporating new technologies and the emergence of new industry
standards could render our existing software products less competitive, obsolete or unmarketable.
16
There can be no assurance that we will be successful in developing and marketing new software products
that respond to technological changes or evolving industry standards. If we are unable, for technological or other
reasons, to develop and introduce new software products cost-effectively, in a timely manner and in response to
changing market conditions or customer requirements, our business, results of operations and financial condition
may be adversely affected.
Developing or implementing new or updated software products and services may take longer and cost more
than expected. We rely on a combination of internal development, strategic relationships, licensing and acquisitions
to develop our software products and services. The cost of developing new healthcare information services and
technology solutions is inherently difficult to estimate. Our development and implementation of proposed software
products and services may take longer than originally expected, require more testing than originally anticipated and
require the acquisition of additional personnel and other resources. If we are unable to develop new or updated
software products and services cost-effectively on a timely basis and implement them without significant disruptions
to the existing systems and processes of our customers, we may lose potential sales and harm our relationships with
current or potential customers.
The failure to attract and retain qualified or key personnel may prevent us from effectively developing,
marketing, selling, integrating and supporting our services.
We are dependent, to a substantial extent, upon the continuing efforts and abilities of certain key
management personnel. In addition, we face competition for experienced employees with professional expertise in
the workers’ compensation managed care area. The loss of key personnel, especially V. Gordon Clemons,
Chairman, President, and Chief Executive Officer, or the inability to attract, qualified employees, could have a
material unfavorable effect on our business and results of operations.
If we lose several customers in a short period, our results may be materially adversely affected.
Our results may decline if we lose several customers during a short period. Most of our customer contracts
permit either party to terminate without cause. If several customers terminate, or do not renew or extend their
contracts with us, our results could be materially and adversely affected. Many organizations in the insurance
industry have consolidated and this could result in the loss of one or more of our customers through a merger or
acquisition. Additionally, we could lose customers due to competitive pricing pressures or other reasons.
We are subject to risks associated with acquisitions of intangible assets.
Our acquisition of other businesses may result in significant increases in our intangible assets and goodwill.
We regularly evaluate whether events and circumstances have occurred indicating that any portion of our intangible
assets and goodwill may not be recoverable. When factors indicate that intangible assets and goodwill should be
evaluated for possible impairment, we may be required to reduce the carrying value of these assets. We cannot
currently estimate the timing and amount of any such charges.
If we are unable to leverage our information systems to enhance our outcome-driven service model, our results
may be adversely affected.
To leverage our knowledge of workplace injuries, treatment protocols, outcomes data, and complex
regulatory provisions related to the workers’ compensation market, we must continue to implement and enhance
information systems that can analyze our data related to the workers’ compensation industry. We frequently upgrade
existing operating systems and are updating other information systems that we rely upon in providing our services
and financial reporting. We have detailed implementation schedules for these projects that require extensive
involvement from our operational, technological and financial personnel. Delays or other problems we might
encounter in implementing these projects could adversely affect our ability to deliver streamlined patient care and
outcome reporting to our customers.
Our Internet-based services are dependent on the development and maintenance of the Internet infrastructure.
17
The Internet has experienced a variety of outages and other delays as a result of damages to portions of its
infrastructure, and it could face outages and delays in the future. These outages and delays could reduce the level of
Internet usage, as well as the availability of the Internet to us for delivery of our Internet-based services. In addition,
our customers who use our Web-based services depend on Internet service providers, online service providers and
other Web site operators for access to our Web site. All of these providers have experienced significant outages in
the past and could experience outages, delays and other difficulties in the future due to system failures unrelated to
our systems. Any significant interruptions in our services or increases in response time could result in a loss of
potential or existing users, and, if sustained or repeated, could reduce the attractiveness of our services.
We are sensitive to regional weather conditions that may adversely affect our operations.
Our operations are directly affected in the short-term by the weather conditions in certain of our regions
of operation. Therefore our business is sensitive to the weather conditions of these regions. Unusually inclement
weather, including significant rain, snow, sleet, freezing rain or ice can temporarily affect our operations if clients
are forced to close operational centers. Accordingly, our operating results may vary from quarter to quarter,
depending on the impact of these weather conditions.
Natural and other disasters may adversely affect our business.
We may be vulnerable to damage from severe weather conditions or natural disasters, including
hurricanes, fires, floods, earthquakes, power loss, communications failures and similar events, including the effects
of war or acts of terrorism. If a disaster were to occur, our ability to operate our business could be seriously or
completely impaired or destroyed. The insurance we maintain may not be adequate to cover our losses resulting
from disasters or other business interruptions.
Item 1B. Unresolved Staff Comments
None.
Item 2. Properties.
The Company’s principal executive office is located in Irvine, California in approximately 12,000 square
feet of leased space. The lease expires in January 2020. The Company leases approximately 92 branch offices in 45
states, which range in size from 500 square feet up to 26,000 square feet. The lease terms for the branch offices
range from monthly to ten years and expire through 2020. The Company believes that its facilities are adequate for
its current needs and that suitable additional space will be available as required.
Item 3. Legal Proceedings.
The Company is involved in litigation arising in the normal course of business. Management believes that
resolution of these matters will not result in any payment that, in the aggregate, would be material to the financial
position or results of the operations of the Company.
Item 4. Mine Safety Disclosures.
Not applicable.
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
18
Market Information
The Company’s common stock is traded on the NASDAQ Global Select Market under the symbol CRVL.
The quarterly high and low per share sales prices for the Company’s common stock for fiscal years 2012 and 2013
as reported by NASDAQ are set forth below for the periods indicated. These prices represent prices among dealers,
do not include retail markups, markdowns or commissions, and may not represent actual transactions.
Holders. As of May 28, 2013, there were approximately 1,390 holders of record of the Company’s
common stock according to the information provided by the Company’s transfer agents.
Dividends. The Company has never paid any cash dividends on its common stock and has no current plans
to do so in the foreseeable future. The Company intends to retain future earnings, if any, for use in the Company’s
business. The payment of any future dividends on its common stock will be determined by the Board of Directors in
light of conditions then existing, including the Company’s earnings, financial condition and requirements,
restrictions in financing agreements, business conditions and other factors.
Unregistered Sales of Equity Securities. None.
Issuer Purchases of Equity Securities: The following table summarizes purchases of the Company’s
common stock made by or on behalf of the Company for the quarter ended March 31, 2013 pursuant to a publicly
announced plan.
In 1996, the Company’s Board of Directors authorized a stock repurchase program initially for up to
100,000 shares of the Company’s common stock. The Company’s Board of Directors has periodically increased the
number of shares authorized for repurchase under the program. In February 2012, the board authorized an increase
in the number of shares to be repurchased over the life of the program to 16,000,000. As of March 31, 2013, the
Company has repurchased 15,658,507 shares its common stock. There is no expiration date for the plan.
19
HighLowFiscal Year Ended March 31, 2012:Quarter Ended June 30, 2011:$54.19$42.64Quarter Ended September 30, 2011:51.5438.04Quarter Ended December 31, 2011:54.6440.67Quarter Ended March 31, 2012:54.2339.46Fiscal Year Ended March 31, 2013:Quarter Ended June 30, 2012:$49.83$39.71Quarter Ended September 30, 2012:51.3642.91Quarter Ended December 31, 2012:45.7240.31Quarter Ended March 31, 2013:50.0042.57PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced ProgramMaximum Number of Shares that may yet be Purchased Under the ProgramJanuary 1 to January 31, 201356,930 $44.2456,930435,927February 1 to February 29, 201350,741 47.0350,741385,186March 1 to March 31, 201343,753 48.8843,753341,433Total151,424$46.67151,424341,433
STOCK PERFORMANCE GRAPH
The graph depicted below shows a comparison of cumulative total stockholder returns for the Company,
the Nasdaq and the Nasdaq Health Services Index over a five year period beginning on March 31, 2008. The data
depicted on the graph are as set forth in the chart below the graph. The graph assumes that $100 was invested in the
Company’s Common Stock on March 31, 2008, and in each index, and that all dividends were reinvested. No cash
dividends have been paid or declared on the Common Stock. Stockholder returns over the indicated period should
not be considered indicative of future stockholder returns.
CorVel Corporation
U.S. Nasdaq
U.S. Nasdaq Healthcare Services
2008
100.00
100.00
100.00
2009
66.10
67.07
81.42
2010
116.87
105.22
113.63
2011
173.85
122.02
121.50
2012
130.40
135.65
138.94
2013
161.78
143.37
178.39
Notwithstanding anything to the contrary set forth in any of our previous filings made under the Securities
Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, that might incorporate future filings
made by us under those statutes, neither the preceding Stock Performance Graph, nor the information relating to it,
is “soliciting material” or is “filed” or is to be incorporated by reference into any such prior filings, nor shall such
graph or information be incorporated by reference into any future filings made by us under those statutes.
20
0.0020.0040.0060.0080.00100.00120.00140.00160.00180.00200.00March 31, 2008March 31, 2009March 31, 2010March 31, 2011March 31, 2012March 31, 2013CorVel Stock Performance GraphCorVelNasdaq U.S.Nasdaq Health
Item 6. Selected Financial Data.
The selected consolidated financial data of the Company appears in a separate section of this Annual
Report on Form 10-K in front of the Management Discussion and Analysis and is incorporated herein by this
reference.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Management’s Discussion and Analysis of Financial Condition and Results of Operations appears in a
separate section of this Annual Report on Form 10-K and is incorporated herein by this reference.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
As of March 31, 2013, the Company held no market risk sensitive instruments for trading purposes and the
Company did not employ any derivative financial instruments, other financial instruments, or derivative commodity
instruments to hedge any market risk. The Company had no debt outstanding as of March 31, 2013, and therefore,
had no market risk related to debt.
Item 8. Financial Statements and Supplementary Data.
The Company’s consolidated financial statements, as listed under Item 15, appear in a separate section of
this Annual Report on Form 10-K and are incorporated herein by this reference. The financial statement schedule is
included below under Item 15(a) (2).
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
None.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and
Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in
Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based upon that evaluation, our Chief Executive Officer
and Chief Financial Officer concluded that, as of March 31, 2013, our disclosure controls and procedures were
effective in ensuring that information required to be disclosed by us in the reports filed or submitted by us under the
Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the
Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal
executive and principal accounting officers, or persons performing similar functions, as appropriate to allow timely
decisions regarding required disclosure.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining a system of internal control over financial
reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial
reporting is designed to provide reasonable assurance regarding the reliability of our financial reporting and
preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting
principles. Internal control over financial reporting includes maintaining records that in reasonable detail accurately
and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for
21
preparation of our financial statements in accordance with U. S. generally accepted accounting principles; providing
reasonable assurance that our receipts and expenditures are made in accordance with authorizations of our
management and directors; and providing reasonable assurance that unauthorized acquisition, use or disposition of
our assets that could have a material effect on our financial statements would be prevented or detected on a timely
basis. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute
assurance that a misstatement of our financial statements would be prevented or detected.
Management conducted an assessment of the effectiveness of our internal control over financial reporting
based on the framework set forth in Internal Control — Integrated Framework issued by the Committee of
Sponsoring Organizations of the Treadway Commission. Based on this assessment, our management concluded that
our internal control over financial reporting was effective as of March 31, 2013 to provide reasonable assurance
regarding the reliability of financial reporting and preparation of financial statements for external reporting purposes
in accordance with U.S. generally accepted accounting principles.
Our independent registered public accounting firm, Haskell & White LLP, has issued an audit report on the
effectiveness of our internal control over financial reporting as of March 31, 2013 as stated in their report that is
included in Part II, Item 8 herein.
Changes to Internal Control over Financial Reporting
During the quarter ended March 31, 2013, there were no changes in our internal control over financial
reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are
reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information.
None.
Item 10. Directors, Executive Officers and Corporate Governance.
PART III
The information in the sections titled “Proposal One: Election of Directors,” “Corporate Governance, Board
Composition and Board Committees,” “Executive Officers of CorVel,” and “Section 16(a) Beneficial Ownership
Reporting Compliance” appearing in the Company’s Definitive Proxy Statement for the 2013 Annual Meeting of
Stockholders is incorporated herein by reference.
The Board of Directors has adopted a code of ethics and business conduct that applies to all of the
Company’s employees, officers and directors. The full text of the Company’s code of ethics and business conduct is
posted on the Company’s web site at www.corvel.com under the “Investor Relations” section. The Company intends
to disclose future amendments to certain provisions of the Company’s code of ethics and business conduct, or
waivers of such provisions, applicable to the Company’s directors and executive officers, at the same location on the
Company’s web site identified above. The inclusion of the Company’s web site address in this report does not
include or incorporate by reference the information on the Company’s web site into this report.
Item 11. Executive Compensation.
The information in the sections titled “Executive Compensation,” “Compensation Discussion and Analysis,”
“Compensation Committee Interlocks and Insider Participation,” “Compensation Committee Report,” and
“Compensation of Directors,” appearing in the Company’s Definitive Proxy Statement for the 2013 Annual Meeting
of Stockholders is incorporated herein by reference.
22
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The information in the sections titled “Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matter” and “Equity Compensation Plan Information” appearing in the Company’s
Definitive Proxy Statement for the 2013 Annual Meeting of Stockholders is incorporated herein by reference.
Item 13. Certain Relationships and Related Party Transactions, and Director Independence.
The information in the sections titled “Certain Relationships and Related Person Transactions,” “Proposal
One: Election of Directors,” and “Corporate Governance, Board Composition and Board Committees” appearing in
the Company’s Definitive Proxy Statement for the 2013 Annual Meeting of Stockholders is incorporated herein by
reference.
Item 14. Principal Accounting Fees and Services.
The information under the captions “Principal Accountant Fees and Services”, “Audit Committee Pre-
Approval of Audit and Permissible Non-Audit Services of Independent Auditors” and “Ratification of Appointment
of Independent Auditors” appearing in the Company’s Definitive Proxy Statement for the 2013 Annual Meeting of
Stockholders is incorporated herein by reference.
Item 15. Exhibits, Financial Statement Schedules.
(a)(1) Financial Statements:
PART IV
The Company’s financial statements appear in a separate section of this Annual Report on Form 10-K
beginning on the pages referenced below:
Report of Independent Registered Public Accounting Firm .......................................................................
45
Consolidated Statements of Income for the Fiscal Years Ended March 31, 2011, 2012, and 2013 .............
46
Consolidated Balance Sheets as of March 31, 2012 and 2013 .....................................................................
47
Consolidated Statements of Stockholders’ Equity for the Fiscal Years Ended March 31, 2011, 2012,
and 2013 .....................................................................................................................................................
48
Consolidated Statements of Cash Flows for the Fiscal Years Ended March 31, 2011, 2012, and 2013 ......
49
Notes to Consolidated Financial Statements ................................................................................................
50
Page
23
(2) Financial Statement Schedule:
The Company’s consolidated financial statements, as listed under Item 15(a) (1), appear in a separate
section of this Annual Report on Form 10-K.. The Company’s financial statement schedule is as follows:
Schedule II — Valuation and Qualifying Accounts
24
Balance at Beginning of YearAdditions Charged to Cost and ExpensesDeductionsBalance at End of YearAllowance for doubtful accounts:Fiscal Year Ended March 31, 2013: $ 2,395,000 $ 2,123,000 $ (2,223,000)2,295,000$ Fiscal Year Ended March 31, 2012: 2,588,000 2,146,000 (2,339,000)2,395,000 Fiscal Year Ended March 31, 2011: 2,754,000 2,434,000 (2,600,000)2,588,000
(3)
Exhibits:
EXHIBITS
Exhibit
No.
3.1
3.2
3.3
4.1
10.1*
10.2*
10.3*
10.4*
10.5*
Title
Method of Filing
Amended and Restated Certificate of
Incorporation of the Company
Incorporated herein by reference to Exhibit 3.1 to the
Current Report on Form 8-K filed on August 10, 2011.
Amended and Restated Bylaws of the
Company
Certificate of Designation Increasing the
Number of Shares of Series A Junior
Participating Preferred Stock
Second Amended and Restated Preferred
Shares Rights Agreement, dated as of
November 17, 2008, by and between CorVel
Corporation and Computershare Trust
Company, N.A., including the original
Certificate of Designation, the Certificate of
Designation Increasing the Number of
Shares, the form of Right Certificate (as
amended) and the Summary of Rights (as
amended) attached thereto as Exhibits A-1,
A-2, A-3, B and C, respectively
Nonqualified Stock Option Agreement
between V. Gordon Clemons, the Company
and North Star together with all amendments
and addendums thereto
Supplementary Agreement between V.
Gordon Clemons, the Company and North
Star
Amendment to Supplementary Agreement
between Mr. Clemons, the Company and
North Star
Restated Omnibus Incentive Plan (Formerly
The Restated 1988 Executive Stock Option
Plan)
Forms of Notice of Grant of Stock Option,
Stock Option Agreement and Notice of
Exercise Under the Restated Omnibus
Incentive Plan (Formerly The Restated 1988
Executive Stock Option)
Incorporated herein by reference to Exhibit 3.2 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended June 30, 2006 filed on August
14, 2006.
Incorporated herein by reference to Exhibit 3.1 to the
Company’s Form 8-K filed on November 24, 2008.
Incorporated herein by reference to Exhibit 4.1 to the
Company’s Form 8-K filed on November 24, 2008.
Incorporated herein by reference to Exhibit 10.6 to the
Company’s Registration Statement on Form S-1
Registration No. 33-40629 initially filed on May 16,
1991.
Incorporated herein by reference to Exhibit 10.7 to the
Company’s Registration Statement on Form S-1
Registration No. 33-40629 initially filed on May 16,
1991.
Incorporated herein by reference to Exhibit 10.5 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 1992 filed on June 29, 1992.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on
August 10, 2011.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended September 30, 2006 filed on
November 9, 2006, Exhibits 10.7, 10.8 and 10.9 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 1994 filed on June 29, 1994,
Exhibits 99.2, 99.3, 99.4, 99.5, 99.6, 99.7 and 99.8 to
the Company’s Registration Statement on Form S-8
(File No. 333-94440) filed on July 10, 1995, and
Exhibits 99.3 and 99.5 to the Company’s Registration
Statement on Form S-8 (File No. 333-58455) filed on
July 2, 1998.
25
Exhibit
No.
10.6*
10.7*
10.8
10.9
10.10*
10.11*
10.12†*
10.13†*
10.14*†
10.15
10.16
10.17
Title
Employment Agreement of V. Gordon
Clemons
Restated 1991 Employee Stock Purchase
Plan, as amended
Fidelity Master Plan for Savings and
Investment, and amendments
Second Amended and Restated Preferred
Shares Rights Agreement, dated as of
November 17, 2008, by and between CorVel
Corporation and Computershare Trust
Company, N.A., including the original
Certificate of Designation, the Certificate of
Designation Increasing the Number of
Shares, the form of Rights Certificate (as
amended) and the Summary of Rights (as
amended) attached thereto as Exhibits A-1,
A-2, A-3, B and C, respectively
Employment Agreement effective May 26,
2006 by and between CorVel Corporation
and Dan Starck
Stock Option Agreement and Acceleration
Addendum dated May 26, 2006 by and
between CorVel Corporation and Dan Starck,
providing for time vesting
Stock Option Agreement and Acceleration
Addendum dated May 26, 2006 by and
between CorVel Corporation and Dan Starck,
providing for performance vesting.
Stock Option Agreement dated May 26, 2006
by and between CorVel Corporation and
Scott McCloud, providing for performance
vesting.
Stock Option Agreement dated May 26, 2006
by and between CorVel Corporation and Don
McFarlane, providing for performance
vesting.
Credit Agreement dated May 28, 2009 by
and between CorVel Corporation and Wells
Fargo Bank, National Association.
Revolving Line of Credit Note dated May 28,
2009 by CorVel Corporation in favor of
Wells Fargo Bank, National Association.
Form of Partial Waiver of Automatic Option
Grant executed by Directors
10.18*†
Stock Option Agreement and Acceleration
Addendum dated February 4, 2008 by and
between CorVel Corporation and Dan Starck,
26
Method of Filing
Incorporated herein by reference to Exhibit 10.12 to
the Company’s Registration Statement on Form S-1
Registration No. 33-40629 initially filed on May 16,
1991.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K/A filed on
August 12, 2010.
Incorporated herein by reference to Exhibits 10.16 and
10.16A to the Company’s Registration Statement on
Form S-1 Registration No. 33-40629 initially filed on
May 16, 1991.
Incorporated herein by reference to Exhibit 4.1 to the
Company’s Form 8-K filed on November 24, 2008.
Incorporated herein by reference to Exhibit 10.1 in the
Company’s Form 8-K filed on May 30, 2006.
Incorporated herein by reference to Exhibit 10.2 in the
Company’s Form 8-K filed on May 30, 2006.
Incorporated herein by reference to Exhibit 10.3 to the
Company’s Current Report on Form 8-K filed on May
30, 2006.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on June 2,
2006.
Incorporated herein by reference to Exhibit 10.15 to the
Company’s Annual Report on Form 10-K/A filed on July
6, 2007.
Incorporated herein by reference to Exhibit 10.16 to the
Company’s Current Report on Form 8-K filed on June 4,
2009.
Incorporated herein by reference to Exhibit 10.17 to the
Company’s Current Report on Form 8-K filed on June 4,
2009.
Incorporated herein by reference to Exhibit 10.18 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended September 30, 2007 filed on
November 8, 2007.
Incorporated herein by reference to Exhibit 10.19 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 2008 filed on June 16, 2008.
Exhibit
No.
10.19*†
10.20*†
10.21
10.22*†
10.23*†
10.24*†
10.25*†
10.26*†
10.27
10.28*†
10.29*†
10.30*†
10.31*†
Title
Method of Filing
providing for performance vesting.
Stock Option Agreement dated February 4,
2008 by and between CorVel Corporation
and Scott McCloud, providing for
performance vesting.
Stock Option Agreement dated February 4,
2008 by and between CorVel Corporation
and Don McFarlane, providing for
performance vesting.
Partial Waiver of Automatic Option Grant by
Jean Macino dated February 8, 2008
Stock Option Agreement dated February 24,
2009 by and between CorVel Corporation
and Daniel J. Starck, providing for
performance vesting
Stock Option Agreement dated February 24,
2009 by and between CorVel Corporation
and Scott R. McCloud, providing for
performance vesting
Stock Option Agreement dated February 24,
2009 by and between CorVel Corporation
and Donald C. McFarlane, providing for
performance vesting
Stock Option Agreement dated February 5,
2009 by and between CorVel Corporation
and Diane J. Blaha, providing for
performance vesting
Stock Option Agreement dated February 24,
2009 by and between CorVel Corporation
and Diane J. Blaha, providing for
performance vesting
Summary of Terms of Oral Agreement to
Repurchase Shares of Common Stock held
by V. Gordon Clemons.
Incorporated herein by reference to Exhibit 10.20 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 2008 filed on June 16, 2008.
Incorporated herein by reference to Exhibit 10.21 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 2008 filed on June 16, 2008.
Incorporated herein by reference to Exhibit 10.22 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 2008 filed on June 16, 2008.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Form 8-K filed on March 2, 2009.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Form 8-K filed on March 2, 2009.
Incorporated herein by reference to Exhibit 10.3 to the
Company’s Form 8-K filed on March 2, 2009.
Incorporated herein by reference to Exhibit 10.25 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 2009 filed on June 12, 2009.
Refiled herewith.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the
quarter ended December 31, 2009 filed on February 5,
2010.
Stock Option Agreement granted
November 2, 2009 by and between CorVel
Corporation and Daniel J. Starck, providing
for performance vesting.
Stock Option Agreement granted
November 2, 2009 by and between CorVel
Corporation and Scott R. McCloud,
providing for performance vesting.
Stock Option Agreement granted
November 2, 2009 by and between CorVel
Corporation and Donald C. McFarlane,
providing for performance vesting
Stock Option Agreement granted
November 2, 2009 by and between CorVel
Corporation and Diane J. Blaha, providing
for performance vesting.
Refiled herewith.
Refiled herewith.
Refiled herewith.
Refiled herewith.
27
Exhibit
No.
10.32
10.33
10.34
10.35
Title
First Amendment to Credit Agreement dated
June 2, 2010 by and between CorVel
Corporation and Wells Fargo Bank, National
Association.
Revolving Line of Credit Note dated June 2,
2010 by CorVel Corporation in favor of
Wells Fargo Bank, National Association.
Settlement Agreement and General Release
between Corvel Corporation and Kathleen
Roche, D.C., individually and on behalf of
others similarly situated, dated October 29,
2010.
Summary of Terms of Oral Agreement to
Repurchase Shares of Common Stock held
by Corstar Holdings, Inc.
10.36*†
Stock Option Agreement dated December 6,
2010 between the company and Daniel J.
Starck, providing performance vesting.
Method of Filing
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on June 7,
2010.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on June 7,
2010.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended September 30, 2010 filed on
November 8, 2010.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended September 30, 2010 filed on
November 8, 2010.
Refiled herewith.
10.37*†
Stock Option Agreement dated December 6,
2010 between the company and Scott R.
McCloud, providing performance vesting.
Refiled herewith.
10.38*†
Stock Option Agreement dated December 6,
2010 between the company and Donald C.
McFarlane, providing performance vesting.
Refiled herewith.
10.39*†
Stock Option Agreement dated December 6,
2010 between the company and Diane Blaha,
providing performance vesting.
Refiled herewith.
10.40
10.41
10.42
10.43*†
Settlement Agreement dated June 23, 2011
by and among CorVel Corporation and
counsel for class representatives, George
Raymond Williams, M.D., Orthopaedic
Surgery, A Profession Medical, L.L.C. and
Southwest Louisiana Hospital Association
d/b/a Lake Charles Memorial Hospital, and
all other class members.
Second Amendment to Credit Agreement
dated September 1, 2011 by and between
CorVel Corporation and Wells Fargo Bank,
National Association.
Revolving Line of Credit Note dated
September 1, 2011 by CorVel Corporation in
favor of Wells Fargo Bank, National
Association.
Stock option agreement dated November 3,
2011, between the Company and Daniel J.
Starck, providing performance vesting.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended June 30, 2011 filed on August 5,
2011.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on August
31, 2011.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on August
31, 2011.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2011 filed on
February 6, 2012.
28
Exhibit
No.
10.44*†
Title
Method of Filing
Stock option agreement dated November 3,
2011, between the Company and Scott R.
McCloud, providing performance vesting.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2011 filed on
February 6, 2012.
Incorporated herein by reference to Exhibit 10.3 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2011 filed on
February 6, 2012.
Incorporated herein by reference to Exhibit 10.4 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2011 filed on
February 6, 2012.
Incorporated herein by reference to Exhibit 10.5 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2011 filed on
February 6, 2012
Filed herewith.
Filed herewith.
Filed herewith.
Filed herewith.
Furnished herewith.
Furnished herewith.
10.45*†
Stock option agreement dated November 3,
2011, between the Company and Donald C.
McFarlane, providing performance vesting.
10.46*†
Stock option agreement dated November 3,
2011, between the Company and Diane
Blaha, providing performance vesting.
10.47*†
Stock option agreement dated November 3,
2011, between the Company and V. Gordon
Clemons, Jr., providing performance vesting.
21.1
23.1
31.1
31.2
32.1
32.2
101.0
Subsidiaries of the Company
Consent of Independent Registered Public
Accounting Firm, Haskell & White LLP
Certification of the Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-
Oxley Act of 2002.
Certification of the Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-
Oxley Act of 2002.
Certification of the Chief Executive Officer
Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
Certification of the Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
The following materials from CorVel
Corporation's Annual Report on Form 10-K
for the fiscal year ended March 31, 2012,
formatted in XBRL (eXtensible Business
Reporting Language): (i) Consolidated
Balance Sheets as of March 31, 2012 and
March 31, 2011; (ii) Consolidated Statements
of Income for the fiscal years ended March
31, 2012, 2011 and 2010; (iii) Consolidated
Statements of Stockholders' Equity for the
fiscal years ended March 31, 2012, 2011 and
2010; (iv) Consolidated Statements of Cash
Flows for the fiscal years ended March 31,
2012, 2011 and 2010; and (v) Notes to
Consolidated Financial Statements(**)
29
* - Denotes management contract or compensatory plan or arrangement.
** - Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101.0 hereto are deemed not
filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933,
as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as
amended, and otherwise are not subject to liability under those sections.
† - Confidential treatment has been requested for certain confidential portions of this exhibit pursuant to Rule 24b-2
under the Securities Exchange Act of 1934. In accordance with Rule 24b-2, these confidential portions have been
omitted from this exhibit and filed separately with the Securities and Exchange Commission.
(b) Exhibits
The exhibits filed as part of this report are listed under Item 15(a)-(3) of this Annual Report on Form 10-K.
(c) Financial Statement Schedule
The Financial Statement Schedules required by Regulation S-X and Item 8 of Form 10-K are listed under Item
15(a)(2) of this Annual Report on Form 10-K.
30
Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SIGNATURES
CORVEL CORPORATION
By:
/s/ V. GORDON CLEMONS
V. Gordon Clemons
Chairman of the Board, President, and Chief
Executive Officer
Date: June 10, 2013
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the
following persons on behalf of the Registrant and in the capacities indicated on June 10, 2013.
Signature
Title
/s/ V. GORDON CLEMONS
V. Gordon Clemons
Chairman of the Board, Chief Executive Officer, and President
(Principal Executive Officer)
/s/ SCOTT R. MCCLOUD
Scott R. McCloud
Chief Financial Officer (Principal Financial and
Accounting Officer)
/s/ ALAN HOOPS
Alan Hoops
/s/ STEVEN J. HAMERSLAG
Steven J. Hamerslag
/s/ JUDD JESSUP
Judd Jessup
/s/ JEAN MACINO
Jean Macino
/s/ JEFFREY J. MICHAEL
Jeffrey J. Michael
Director
Director
Director
Director
Director
31
SELECTED CONSOLIDATED FINANCIAL DATA
The following selected financial data for each of the five fiscal years ended March 31, 2013, have been
derived from the Company’s audited consolidated financial statements. The following data should be read in
conjunction with the Company’s Consolidated Financial Statements, the related notes thereto, and “Management’s
Discussion and Analysis of Financial Condition and Results of Operations.” The following amounts are in
thousands, except per share data.
32
20092010201120122013Statement of Income Data:Revenues310,076$ 337,968$ 380,668$ 412,668$ 429,310$ Cost of revenues236,334252,429284,098318,826337,650Gross profit73,74285,53996,57093,84291,660General and administrative42,13342,05659,16750,40547,765Income before income taxes31,60943,48337,40343,43743,895Income tax provision12,33217,38712,74016,88517,165Net income19,277$ 26,096$ 24,663$ 26,552$ 26,730$ Net income per share:Basic $ 1.43 $ 2.09 $ 2.09 $ 2.31 $ 2.40 Diluted $ 1.42 $ 2.06 $ 2.05 $ 2.28 $ 2.38 Shares used in computing net income per share:Basic13,45812,49911,80111,47611,128Diluted13,62012,67212,02911,62711,229Return on beginning of year equity20.0%27.1%25.8%26.6%24.2%Return on beginning of year assets13.7%19.0%17.6%16.2%15.6%20092010201120122013Balance Sheet Data as of March 31,Cash and cash equivalents $ 13,217 $ 10,242 $ 12,269 $ 6,597 $ 19,822 Accounts receivable, net 41,249 43,930 48,964 49,334 49,105 Working capital 28,096 27,196 27,389 36,485 40,145 Total assets 137,552 140,368 164,225 171,882 182,382 Retained earnings 197,735 223,831 248,494 275,046 301,776 Treasury stock (185,762) (218,323) (248,931) (270,574) (301,301)Total stockholders’ equity 96,297 95,728 99,639 110,382 111,402 Fiscal Year Ended March 31,
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Management’s Discussion and Analysis of Financial Condition and Results of Operations may include
certain forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended, including (without limitation) statements with
respect to anticipated future operating and financial performance, growth and acquisition opportunities and other
similar forecasts and statements of expectation. Words such as “expects,” “anticipates,” “intends,” “plans,”
“predicts,” “believes,” “seeks,” “estimates,” “potential,” “continue,” “strive,” “ongoing,” “may,” “will,” “would,”
“could,” and “should” and variations of these words and similar expressions, are intended to identify these forward-
looking statements. Forward-looking statements made by the Company and its management are based on estimates,
projections, beliefs and assumptions of management at the time of such statements and are not guarantees of future
performance.
The Company disclaims any obligations to update or revise any forward-looking statement based on the
occurrence of future events, the receipt of new information or otherwise. Actual future performance, outcomes and
results may differ materially from those expressed in forward-looking statements made by the Company and its
management as a result of a number of risks, uncertainties and assumptions. Representative examples of these
factors include (without limitation) general industry and economic conditions including a decreasing number of
national claims due to a decreasing number of injured workers; cost of capital and capital requirements; existing and
possible litigation and legal liability in the course of operations and the Company’s ability to resolve such litigation;
cost of capital and capital requirements; competition from other managed care companies; the ability to expand
certain areas of the Company’s business; shifts in customer demands; the ability of the Company to produce market-
competitive software; changes in operating expenses including employee wages, benefits and medical inflation;
governmental and public policy changes, including but not limited to legislative and administrative law and rule
implementation or change; dependence on key personnel; the continued availability of financing in the amounts and
at the terms necessary to support the Company’s future business; and the other risks identified under the heading
“Risk Factors” appearing elsewhere in the report.
Overview
CorVel Corporation is an independent nationwide provider of medical cost containment and managed care
services designed to address the escalating medical costs of workers’ compensation and auto claims. The
Company’s services are provided to insurance companies, third-party administrators (“TPA’s”), governmental
entities, and self-administered employers to assist them in managing the medical costs and monitoring the quality of
care associated with healthcare claims.
Network Solutions Services
The Company’s network solutions services are designed to reduce the price paid by its customers for
medical services rendered in workers’ compensation cases, auto policies and, to a lesser extent, group health
policies. The network solutions offered by the Company include automated medical fee auditing, preferred provider
services, retrospective utilization review, independent medical examinations, and inpatient bill review. Network
solutions services also includes revenue from the Company’s directed care network (CareIQ), including imaging and
physical therapy.
Patient Management Services
In addition to its network solutions services, the Company offers a range of patient management services,
which involve working on a one-on-one basis with injured employees and their various healthcare professionals,
employers and insurance company adjusters. The services are designed to monitor the medical necessity and
appropriateness of healthcare services provided to workers’ compensation and other healthcare claimants and to
expedite return to work. The Company offers these services on a stand-alone basis, or as an integrated component of
its medical cost containment services. Patient management services include the processing of claims for self-insured
payors to property and casualty insurance.
33
Organizational Structure
The Company’s management is structured geographically with regional vice-presidents who report to the
Chief Executive Office of the Company. Each of these regional vice-presidents is responsible for all services
provided by the Company in his or her particular region and responsible for the operating results of the Company in
multiple states. These regional vice presidents have area and district managers who are also responsible for all
services provided by the Company in their given area and district.
Business Enterprise Segments
The Company operates in one reportable operating segment, managed care. The Company’s services are
delivered to its customers through its local offices in each region and financial information for the Company’s
operations follows this service delivery model. All regions provide the Company’s patient management and network
solutions services. FASB ASC 280-10 establishes standards for the way that public business enterprises report
information about operating segments in annual and interim consolidated financial statements. The Company’s
internal financial reporting is segmented geographically, as discussed above, and managed on a geographic rather
than service line basis, with virtually all of the Company’s operating revenue generated within the United States.
Under FASB ASC 280-10, two or more operating segments may be aggregated into a single operating
segment for financial reporting purposes if aggregation is consistent with the objective and basic principles, if the
segments have similar economic characteristics, and if the segments are similar in each of the following areas: 1) the
nature of products and services; 2) the nature of the production processes; 3) the type or class of customer for their
products and services; and 4) the methods used to distribute their products or provide their services. The Company
believes each of its regions meet these criteria as each provides similar services and products to similar customers
using similar methods of productions and similar methods to distribute the services and products.
Because we believe we meet each of the criteria set forth above and each of our regions have similar
economic characteristics, we aggregate our results of operations in one reportable operating segment, managed care.
Seasonality
While we are not directly impacted by seasonal shifts, we are affected by the change in working days in a
given quarter. There are generally fewer working days for our employees to generate revenue in the third fiscal
quarter as we experience vacations, inclement weather and holidays.
Summary of Fiscal 2013 Annual Results
The Company had revenues of $429 million for fiscal year ended March 31, 2013, an increase of $17
million, or 4%, compared to $413 million for fiscal year ended March 31, 2012. The increase was primarily due to
growth in the TPA services within patient management. This growth was partially offset by a decline in revenue
related to our case management and higher margin network solutions business.
During fiscal 2013, the Company’s gross profit dropped to $91.7 million from $93.8 million in fiscal 2012.
The decrease was primarily attributable to the loss of business with higher margins replaced by business with lower
margins. The Company had record revenues in fiscal 2013; however, gross profit decreased $2.1 million from fiscal
2012 to fiscal 2013.
During fiscal 2013, the Company continued to improve its accounts receivable collections processes and
reduced its days sales outstanding (“DSO”) from 43 days at March 31, 2012 to 40 days at March 31, 2013. The days
sales outstanding at March 31, 2013 is the lowest for a fiscal year end in the history of the Company. This decrease
is due to improved technology and consolidation of collections. We expect DSO to remain around 40 days.
34
During fiscal 2013, the Company’s general and administrative expenses dropped to $47.8 million from
$50.4 million in fiscal 2012. The decrease is primarily due to a reduction in compensation expenses.
During fiscal 2013, the Company also continued to repurchase shares of its common stock under a plan
originally approved by the Company’s Board of Directors in 1996. In February 2012, the Company’s Board of
Directors increased the number of shares authorized to be repurchased over the life of the plan to 16,000,000 shares.
During fiscal 2013, the Company spent $30.7 million to repurchase 705,406 shares of its common stock. Since
commencing this program in the fall of 1996, the Company has repurchased 15,658,507 shares of its common stock
through March 31, 2013, at a cost of $301 million. These repurchases were funded primarily from the Company’s
operating cash flows.
Results of Operations
The Company derives its revenues from providing patient management and network solutions services to
payors of workers’ compensation benefits, auto insurance claims and health insurance benefits. Patient management
services include utilization review, medical case management, vocational rehabilitation, and claims processing.
Network solutions revenues include fee schedule auditing, hospital bill auditing, independent medical examinations,
diagnostic imaging review services and preferred provider referral services. The percentages of total revenues
attributable to patient management and network solutions services for the fiscal years ended March 31, 2011, 2012,
and 2013 are listed below.
As noted in the table above, from fiscal 2012 to fiscal 2013 the mix of the Company’s revenues moved 2.2
percentage points from network solutions to patient management. This mix shift is primarily due to the Company’s
increased focus in the sale of TPA services which are included with patient management services. The Company
expects to have more growth in the sale of TPA services than its other services.
35
201120122013Patient management services47.0%49.3%51.5%Network solutions services53.0%50.7%48.5%100.0%100.0%100.0%
The following table shows the income statements for the past three fiscal years and the dollar changes as
well as the percentage changes for each fiscal year in thousands, except for per share information.
As previously identified in the section titled “Risk Factors” in this report, the Company’s ability to
maintain or grow revenues is subject to several risks including, but not limited to, changes in government
regulations, exposure to litigation and the ability to add or retain customers. Any of these, or a combination of all of
them, could have a material and adverse effect on the Company’s results of operations going forward.
The following table sets forth, for the periods indicated, the percentage of revenues represented by certain
items reflected in the Company’s consolidated statements of income. The Company’s past operating results are not
necessarily indicative of future operating results. The percentages for the three fiscal years ended March 31, 2011,
2012 and 2013 are as follows:
36
Fiscal2011Fiscal2012Fiscal2013Amount Change from Fiscal 2011 to 2012Amount Change from Fiscal 2012 to 2013Percent Change from Fiscal 2011 to 2012Percent Change from Fiscal 2012 to 2013Revenues$380,668 $412,668 $429,310 $32,000 $16,642 8.4%4.0%Cost of revenues284,098318,826337,65034,728 18,824 12.25.9Gross profit96,57093,84291,660(2,728)(2,182)(2.8)(2.3)General and administrative 59,16750,40547,765(8,762)(2,640)(14.8)(5.2)Income before income taxes37,40343,43743,8956,034 458 16.11.1Income tax provision12,740 16,885 17,165 4,145 280 32.51.7Net income$24,663$26,552$26,730$1,889 $178 7.7%0.7%Net income per share:Basic $ 2.09 $ 2.31 $ 2.40 $ 0.22 $ 0.09 10.5%3.9%Diluted $ 2.05 $ 2.28 $ 2.38 $ 0.23 $ 0.10 11.2%4.4%Shares used in net income per share:Basic11,80111,47611,128(325)(348)(2.8%)(3.0%)Diluted12,02911,62711,229(402)(398)(3.3%)(3.4%)201120122013Revenues100.0%100.0%100.0%Cost of revenues74.6%77.3%78.6%Gross profit25.4%22.7%21.4%General and administrative 15.5%12.2%11.1%Income before income taxes9.9%10.5%10.3%Income tax provision3.3%4.1%4.1%Net Income6.6%6.4%6.2%
Revenue
The Company derives its revenues from providing patient management and network solutions services to
payors of workers’ compensation benefits, auto insurance claims and health insurance benefits. Patient management
services include claims administration, utilization review, medical case management and vocational rehabilitation.
Network solutions revenues include fee schedule auditing, hospital bill auditing, independent medical examinations,
diagnostic imaging review services, directed care services and preferred provider referral services.
Change in Revenue
Fiscal 2013 Compared to Fiscal 2012
Revenues increased by 4%, to $429 million in fiscal 2013, from $413 million in fiscal 2012, an increase of
$17 million. The increase was primarily due to growth in the TPA services within patient management. This
growth was partially offset by a decline in revenue related to our case management and higher margin network
solutions business. Patient management revenues, which include TPA services increased by $23 million, or 11.4%,
from $198 million to $221 million. Network solutions services decreased by $7 million, or 2.8%, from $215 million
to $208 million.
Fiscal 2012 Compared to Fiscal 2011
Revenues increased by 8% to $413 million in fiscal 2012, from $381 million in fiscal 2011, an increase of
$32 million. The increase was primarily due to an increase in revenues from claims administration customers of our
patient management service, due both to an increase in such customers and an increase in the services sold to
existing claims administration customers. Additionally, to a lesser extent, the Company had an increase in network
solutions revenues from an increase in pharmacy services. Patient management revenues increased by $19 million,
or 11%, from $179 million to $198 million. Network solutions services increased by $13 million, or 6%, from $202
million to $215 million.
Cost of Revenue
The Company’s cost of revenues consist of direct expenses, costs directly attributable to the generation of
revenue, and field indirect costs which are incurred in the field to support the operations in the field offices which
generate the revenue. Direct costs are primarily case manager salaries, bill review analysts, related payroll taxes and
fringe benefits, and costs for Independent Medical Examinations (IME), prescription drugs, and MRI providers.
Most of the Company’s revenues are generated in offices which provide both patient management services and
network solutions services. The largest of the field indirect costs are manager salaries and bonus, account executive
base pay and commissions, administrative and clerical support, field systems personnel, PPO network developers,
related payroll taxes, fringe benefits, office rent, and telephone expense. During fiscal 2013, approximately 32% of
the costs incurred in the field are field indirect costs which support both the patient management services and
network solutions operations of the Company’s field operations.
37
Change in Cost of Revenue
Fiscal 2013 Compared to Fiscal 2012
The Company’s cost of revenues increased from $319 million in fiscal 2012 to $338 million in fiscal 2013,
an increase of 5.9% or $19 million. The Company had record revenues in fiscal 2013; however, gross profit
decreased $2.1 million from fiscal 2012 to fiscal 2013. The increase in cost of revenues is primarily due to the 4%
increase in revenues noted above along with the loss of some higher margin business replace by some lower margin
business. Pharmacy costs increased from $43 million to $51 million due to an increase in revenue in this line of
business. Additionally direct labor increased from $84 million to $92 million due to increased services to TPA
customers. During the past two fiscal years, the Company’s gross margin decreased from 23% to 21%. These
margins will not improve unless the Company is either able to sell additional higher margin services or develop
operating efficiencies.
Fiscal 2012 Compared to Fiscal 2011
The Company’s cost of revenues increased from $284 million in fiscal 2011 to $319 million in fiscal 2012,
an increase of 12.2%, or $35 million. The increase in cost of revenues is primarily due to the 8% increase in
revenues noted above along with the loss of some higher margin business replace by some lower margin business.
From fiscal 2011 and 2012, the Company’s gross margin decreased from 25% to 23%. These margins will not
improve unless the Company is either able to sell additional higher margin services or develop operating
efficiencies.
General and Administrative Expense
During fiscals years 2011, 2012 and 2013, approximately 54%, 56%, and 60% respectively, of general and
administrative costs (exclusive of the $9.0 million Louisiana legal settlement accrual in fiscal 2011,) consisted of
corporate systems costs, which include the corporate systems support, implementation and training, rules engine
development, national information technology (IT) strategy and planning, depreciation of the hardware costs in the
Company’s corporate offices and backup data center, the Company’s national wide area network, and other systems
related costs. The Company includes all IT related costs managed by the corporate office in general and
administrative whereas the field IT related costs are included in the cost of revenues. The remaining general and
administrative costs consist of national marketing, national sales support, corporate legal, corporate insurance,
human resources, accounting, product management, new business development, and other general corporate
expenses.
Change in General and Administrative Expense
Fiscal 2013 Compared to Fiscal 2012
General and administrative expense decreased 5.3% from $50 million in fiscal 2012 to $47.8 million in
fiscal 2013. In fiscal 2013, the Company reduced compensation expenses, due to a lower headcount and lower
annual bonuses. Stock compensation also decreased from $1.8 million to $0.5 million due to the Company’s failure
to achieve the targets on performance stock options.
The costs associated with the development and maintenance of software products and the implementation
and incorporation of new technologies to remain competitive could have a material adverse effect on the Company’s
results of operations in the future. Likewise, the Company’s exposure to litigation and increasing costs of insurance
could have a material adverse effect on the Company’s results of operations as well.
Fiscal 2012 Compared to Fiscal 2011
General and administrative expense decreased 14.8% from $59 million in fiscal 2011 to $50 million in
fiscal 2012. In fiscal 2011, the general and administrative costs include $9 million for the costs to settle litigation in
Louisiana, which the Company did not have in fiscal 2012. Excluding the costs of this litigation, general and
38
administrative expense was flat between fiscal 2011 and fiscal 2012. Systems related costs increased from $25
million in fiscal 2011 to $28 million in fiscal 2012. All other general and administrative expense decreased from
$25 million in fiscal 2011 to $22 million in fiscal 2012.
Income Tax Provision
Fiscal 2013 Compared to Fiscal 2012
The Company’s income tax expense for fiscal years 2012 and 2013 was $17 million. The income tax
expense was calculated based on a 39% tax rate that was consistent for both fiscal years.
Fiscal 2012 Compared to Fiscal 2011
The Company’s income tax expense for fiscal years 2011 and 2012, was $13 million and $17 million,
respectively. The Company’s income tax expense in fiscal 2012 increased primarily due to the increase in pre-tax
income from $37 million in fiscal 2011 to $43 million in fiscal 2012. The effective income tax rates for fiscal years
2011 and 2012 were 35% and 39% respectively. The increase in the effective income tax rate was primarily due to
the recognition of a net benefit of $1,601,000 in fiscal 2011 due to the reduction in the FIN 48 liability originally
recorded based upon review of the FIN 48 liability. The Company did not have any such adjustment in fiscal 2012.
These rates differed from the statutory federal tax rate of 35% primarily due to state income taxes and certain non-
deductible expenses.
Net Income
Fiscal 2013 Compared to Fiscal 2012
The Company’s net income for fiscal years 2012 and 2013 was $26.6 million and $26.7 million,
respectively. The Company’s net income in fiscal 2013 increased due to the aforementioned drop in gross profit
slightly offset by the drop in general and administrative costs.
Fiscal 2012 Compared to Fiscal 2011
The Company’s net income for fiscal years 2011 and 2012 was $25 million and $27 million, respectively.
The Company’s net income in fiscal 2012 increased due to the accrual of $9 million accrued in fiscal 2011 for the
legal settlement of the Louisiana litigation and Roche litigation offset by the increase in profits from the rest of the
Company’s operations. The Company did not have a similar legal accrual in fiscal 2012.
Earnings per Share
Fiscal 2013 Compared to Fiscal 2012
The Company’s diluted earnings per share for fiscal years 2012 and 2013 were $2.28 and $2.38,
respectively. The Company’s earnings per share in fiscal 2013 increased due to a reduction in shares outstanding
because of the shares repurchased in the Company’s share repurchase program which reduced weighted shares.
Fiscal 2012 Compared to Fiscal 2011
The Company’s diluted earnings per share for fiscal years 2011 and 2012 were $2.05 and $2.28,
respectively. The Company’s earnings per share in fiscal 2012 increased due to the accrued legal settlement of the
Louisiana litigation in fiscal 2011 and due to a reduction in shares outstanding because of the shares repurchased in
the Company’s share repurchase program which reduced weighted shares.
39
Liquidity and Capital Resources
Introduction
We manage our liquidity and financial position in the context of our overall business strategy. We
continually forecast and manage our cash, investments, working capital balances and capital structure to meet the
short- and long-term obligations of our businesses while seeking to maintain liquidity and financial flexibility. Cash
flows generated from operating activities are principally from earnings before non-cash expenses. The risk of
decreased operating cash flow from a decline in earnings is partially mitigated by the diversity of our services,
geographies and customers; and our lack of any interest bearing debt for the past 21 years.
The Company has historically funded its operations and capital expenditures primarily from cash flow from
operations, and to a lesser extent, stock option exercises. The Company’s net accounts receivables have averaged
below 43 days of average sales for the past two fiscal years and were at a fiscal year record low at 40 days at March
31, 2013. Property, net of accumulated depreciation, has historically averaged approximately 11% or less of annual
revenue. The Company’s historical profit margins and historical ratio of investments in assets used in the business
has allowed the Company to generate sufficient cash flow to repurchase $301 million of its common stock during
the past fifteen fiscal years, without incurring debt, on inception-to-date net earnings of $301 million. The Company
repurchases shares during periods of excess liquidity which has occurred all 21 years the Company has been public.
Should the Company have lower income or cash flows, it could reduce or eliminate the share repurchase program
until earnings and cash flow improves. Working capital increased from $36 million to $39 million from March 31,
2012 to March 31, 2013.
The Company believes that cash from operations and funds from exercises of stock options granted to
employees are adequate to fund existing obligations, repurchase shares of the Company’s common stock under its
current share repurchase program, introduce new services, and continue to develop healthcare related businesses for
at least the next twelve months. The Company regularly evaluates cash requirements for current operations and
commitments, and for capital acquisitions and other strategic transactions. The Company may elect to raise
additional funds for these purposes, through debt or equity financings or otherwise, as appropriate. Additional equity
or debt financing may not be available when needed, on terms favorable to us or at all.
As of March 31, 2013, the Company had $20 million in cash and cash equivalents, invested primarily in
short-term, interest-bearing highly liquid investment-grade securities with maturities of 90 days or less.
In September 2012, the Company renewed a line of credit agreement. The line is with a financial
institution to provide a revolving credit facility with borrowing capacity of up to $10 million. Borrowings under this
agreement, as amended, bear interest, at the Company’s option, at a fixed LIBOR-based rate plus 1.50% or at a
fluctuating rate determined by the financial institution to be 1.50% above the daily one-month LIBOR rate. The loan
covenants require the Company to maintain the current assets to liabilities ratio of at least 1.25:1, debt to tangible net
worth not greater than 1.25:1 and have positive net income. There were no outstanding revolving loans at any time
during fiscal 2013, or as of the date hereof, but letters of credit in the aggregate amount of $8.0 million have been
issued under a letter of credit sub-limit that does not reduce the amount of borrowings available under the revolving
credit facility. The credit agreement expires in September 2013.
The Company believes that the cash balance at March 31, 2013 along with anticipated internally generated
funds, and the credit facility would be sufficient to meet the Company’s expected cash requirements for at least the
next twelve months.
40
Operating Cash Flows
Fiscal 2013 Compared to Fiscal 2012
Net cash provided by operating activities increased from $36 million in fiscal 2012 to $55 million in fiscal
2013. The increase in cash provided by operations was primarily due to an overpayment of taxes in fiscal 2012
which then reduced the payments during fiscal 2013.
Fiscal 2012 Compared to Fiscal 2011
Net cash provided by operating activities decreased from $45 million in fiscal 2011 to $36 million in fiscal
2012. The decrease in cash provided by operations was primarily due to a decrease in accrued liabilities by $8
million primarily due to the payment of $9 million towards the settlement of the Louisiana litigation. In fiscal 2011,
this amount was accrued resulting in most of the increase in accrued liabilities.
Investing Activities
Fiscal 2013 Compared to Fiscal 2012
Net cash flow used in investing activities decreased from $23 million in fiscal 2012 to $15 million in fiscal
2013. This decrease in investing activity was primarily due to a decrease in property additions from $23 million in
fiscal 2012 to $15 million in fiscal 2013, primarily due to a decrease in amount spent on capitalized software, office
leases, and leasehold improvements. The Company expects future expenditures for property and equipment to
increase if revenues increase.
Fiscal 2012 Compared to Fiscal 2011
Net cash flow used in investing activities increased from $20 million in fiscal 2011 to $23 million in fiscal
2012. This increase in investing activity was primarily due to an increase in property additions from $19 million in
fiscal 2011 to $23 million in fiscal 2012, primarily due to an increase in software development efforts.
Financing Activities
Fiscal 2013 Compared to Fiscal 2012
Net cash flow used in financing activities increased from $18 million in fiscal 2012 to $27 million in fiscal
2013. The increase in cash flow used in financing activities was due to an increase in the purchase of common stock
under the Company’s share repurchase program. During fiscal 2013, the Company spent $31 million to repurchase
705,406 shares of its common stock (at an average price of $43.56 per share). During fiscal 2012, the Company
spent $22 million to repurchase 461,938 shares of its common stock (at an average price of $46.85 per share). The
change noted above was partially offset by a decrease in cash received from option proceeds and related income tax
benefits.
If the Company continues to generate cash flow from operating activities, the Company may continue to
repurchase shares of its common stock on the open market, if authorized by the Company’s Board of Directors, or
seek to identify other businesses to acquire. In February 2012, the Board of Directors increased the number of
shares authorized to be repurchased over the life of the stock repurchase program by an additional 1,000,000 shares
to 16,000,000 shares. The Company has historically used cash provided by operating activities and from the
exercise of stock options to repurchase stock. The Company expects that it may use some of the cash on the balance
sheet at March 31, 2013 to repurchase additional shares of its common stock in the future.
41
Fiscal 2012 Compared to Fiscal 2011
Net cash flow used in financing activities decreased from $23 million in fiscal 2011 to $18 million in fiscal
2012. The decrease in cash flow used in financing activities was due to a decrease in the purchase of common stock
under the Company’s share repurchase program. During fiscal 2011, the Company spent $31 million to repurchase
715,975 shares of its common stock (at an average price of $42.75 per share). During fiscal 2012, the Company
spent $22 million to repurchase 461,938 shares of its common stock (at an average price of $46.85 per share). The
change noted above was partially offset by a decrease in cash received from option proceeds and related income tax
benefits. In fiscal year 2011, the Company realized $7 million in cash from the exercise of stock options and the
related income tax benefits. In fiscal 2012, the Company realized $3 million from the exercise of stock options and
the related income tax benefits.
Contractual Obligations
The following table set forth our contractual obligations at March 31, 2013, which are primarily future
minimum lease payments due under non-cancelable operating leases:
Litigation. The Company is involved in litigation arising in the normal course of business. Management
believes that resolution of these matters will not result in any payment that, in the aggregate, would be material to
the financial position or results of the operations of the Company.
Inflation. The Company experiences pricing pressures in the form of competitive prices. The Company is
also impacted by rising costs for certain inflation-sensitive operating expenses such as labor and employee benefits,
and facility leases. However, the Company generally does not believe these impacts are material to its revenues or
net income.
Off-Balance Sheet Arrangements
The Company is not a party to off-balance sheet arrangements as defined by the Securities and Exchange
Commission. However, from time to time the Company enters into certain types of contracts that contingently
require the Company to indemnify parties against third-party claims. The contracts primarily relate to: (i) certain
contracts to perform services, under which the Company may provide customary indemnification to the purchases of
such services; (ii) certain real estate leases, under which the Company may be required to indemnify property
owners for environmental and other liabilities, and other claims arising from the Company’s use of the applicable
premises; and (iii) certain agreements with the Company’s officers, directors and employees, under which the
Company may be required to indemnify such persons for liabilities arising out of their relationship with the
Company.
The terms of such obligations vary by contract and in most instances a specific or maximum dollar amount
is not explicitly stated therein. Generally, amounts under these contracts cannot be reasonably estimated until a
specific claim is asserted. Consequently, no liabilities have been recorded for these obligations on the Company’s
balance sheets for any of the periods presented.
42
TotalLess than one year1-3 Years3-5 YearsMore than 5 YearsOperating leases$47,797,000$13,527,000$21,494,000$10,457,000$2,319,000Uncertain tax positions771,000771,000 - - - Software license3,516,0001,172,000 1,172,000 1,172,000 - Total$52,084,000$15,470,000$22,666,000$11,629,000$2,319,000For the Fiscal Years Ended March 31:
Critical Accounting Policies
The SEC defines critical accounting policies as those that require application of management’s most
difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters
that are inherently uncertain and may change in subsequent periods.
The following is not intended to be a comprehensive list of our accounting policies. Our significant
accounting policies are more fully described in Note A to the Consolidated Financial Statements. In many cases, the
accounting treatment of a particular transaction is specifically dictated by accounting principles generally accepted
in the United States of America, with no need for management’s judgment in their application. There are also areas
in which management’s judgment in selecting an available alternative would not produce a materially different
result.
We have identified the following accounting policies as critical to us: 1) revenue recognition, 2) allowance
for uncollectible accounts, 3) goodwill and long-lived assets, 4) accrual for self-insured costs, 5) accounting for
income taxes, 6) legal and other contingencies, 7) share-based compensation, and 8) software development costs.
Revenue Recognition: The Company recognizes revenue when there is persuasive evidence of an
arrangement, the services have been provided to the customer, the sales price is fixed or determinable, and
collectability is reasonably assured. For the Company’s services, as the Company’s professional staff performs
work, they are contractually permitted to bill for fees earned in fraction of an hour increments worked or by units of
production. The Company recognizes revenue as the time is worked or as units of production are completed, which
is when the revenue is earned and realized. Labor costs are recognized as the costs are incurred. The Company
derives the majority of its revenue from the sale of Network Solutions and Patient Management services. Network
Solutions and Patient Management services may be sold individually or combined with any of the services the
Company provides. When a sale combines multiple elements, the Company accounts for multiple element
arrangements in accordance with the guidance included in Accounting Standard Codification (“ASC”) 605-25.
Management evaluates agreements with customers in accordance with the provision of the revenue
recognition topic that addresses multiple-deliverable revenue arrangements. The multiple-deliverable arrangements
entered into consist of bundled managed care which included various units of accounting such as network solutions,
and patient management which includes claims administration. Such elements are considered separate units of
accounting due to each element having value to the customer on a stand-alone basis. The selling price for each unit
of accounting is determined using contract price and management estimates. When the Company’s customers
purchase several products the pricing of the products sold is generally the same as if the product were sold on an
individual basis. Revenue is recognized as the work is performed in accordance with our customer contracts. Based
upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same
accounting period. The Company recognizes revenue for patient management claims administration services over
the life of the customer contract. Based upon prior experience in managing claims, the Company estimates the
deferral amount from when the claim is received to when the customer contract expires.
Allowance for Uncollectible Accounts: The Company determines its allowance by considering a number
of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history,
the customers’ current ability to pay its obligation to the Company, and the condition of the general economy and
the industry as a whole. The Company writes off accounts receivable when they become uncollectible.
The Company must make significant management judgments and estimates in determining contractual and
bad debt allowances in any accounting period. One significant uncertainty inherent in the Company’s analysis is
whether its past experience will be indicative of future periods. Although the Company considers future projections
when estimating contractual and bad debt allowances, the Company ultimately makes its decisions based on the best
information available to it at that time. Adverse changes in general economic conditions or trends in reimbursement
amounts for the Company’s services could affect the Company’s contractual and bad debt allowance estimates,
collection of accounts receivable, cash flows, and results of operations. No one customer accounted for 10% or more
of accounts receivable at March 31, 2012, and 2013.
43
Goodwill and Long-Lived Assets: Goodwill arising from business combinations represents the excess of
the purchase price over the estimated fair value of the net assets of the acquired business. Pursuant to ASC 350-10
through ASC 350-30, “Goodwill and Other Intangible Assets,” goodwill is tested annually for impairment or more
frequently if circumstances indicate the potential for impairment. Also, management tests for impairment of its
amortizable intangible assets and long-lived assets annually and whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be recoverable. The Company’s impairment is conducted at a
regional level. The measurement of fair value is based on an evaluation of market capitalization and is further tested
using a multiple of earnings approach. In projecting the Company’s cash flows, management considers industry
growth rates and trends and cost structure changes. Based on the Company’s tests and reviews, no impairment of its
goodwill, intangible assets or other long-lived assets existed at March 31, 2013. However, future events or changes
in current circumstances could affect the recoverability of the carrying value of goodwill and long-lived assets.
Should an asset be deemed impaired, an impairment loss would be recognized to the extent the carrying value of the
asset exceeded its estimated fair market value.
Accrual for Self-insurance Costs: The Company accrues for the group medical costs and workers’
compensation costs of its employees based on claims filed and an estimate of claims incurred but not reported as of
each balance sheet date. The Company purchases stop loss insurance for large claims. The Company determines its
estimated self-insurance reserves based upon historical trends along with outstanding claims information provided
by its claims paying agents. However, it is possible that recorded accruals may not be adequate to cover the future
payment of claims. Adjustments, if any, to estimated accruals resulting from ultimate claim payments will be
reflected in earnings during the periods in which such adjustments are determined. The Company’s self-insured
liabilities contain uncertainties because management is required to make assumptions and to apply judgment to
estimate the ultimate cost to settle reported claims and claims incurred but not reported at the balance sheet date.
The Company does not believe there is a reasonable likelihood that there will be a material change in the
estimates or assumptions used to calculate its self-insured liabilities. However, if actual results are not consistent
with these estimates or assumptions, the Company may be exposed to losses or gains that could be material.
Accounting for Income Taxes: The Company records a tax provision for the anticipated tax consequences
of the reported results of operations. The provision for income taxes is computed using the asset and liability
method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of
temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses
and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates
that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled.
The Company records a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is
believed more likely than not to be realized.
The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the
tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.
The tax benefits recognized in the financial statements from such positions are then measured based on the largest
benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
Management believes it is more likely than not that forecasted income, including income that may be
generated as a result of certain tax planning strategies, together with future reversals of existing taxable temporary
differences, will be sufficient to fully recover the deferred tax assets. In the event that the Company determines all or
part of the net deferred tax assets are not realizable in the future, the Company will make an adjustment to the
valuation allowance that would be charged to earnings in the period such determination is made. In addition, the
calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application
of GAAP and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s
expectations could have a material impact on the Company’s financial condition and operating results. The
significant assumptions and estimates described above are important contributors to our ultimate effective tax rate in
each year.
Legal and Other Contingencies: As discussed in Part I, Item 3 of this Form 10-K under the heading
“Legal Proceedings” and in Note I, “Contingencies and Legal Proceedings” in Notes to Consolidated Financial
Statements, the Company is subject to various legal proceedings and claims that arise in the ordinary course of
business. The Company records a liability when it is probable that a loss has been incurred and the amount is
44
reasonably estimable. There is significant judgment required in both the probability determination and as to whether
an exposure can be reasonably estimated. In the opinion of management, there was not at least a reasonable
possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with
respect to loss contingencies. However, the outcome of legal proceedings and claims brought against the Company
are subject to significant uncertainty.
Share-Based Compensation: The Company accounts for share based compensation in accordance with the
provisions of ASC Topic 718 “Compensation – Stock Compensation”. Under ASC 718, share-based compensation
cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense
over the employee’s requisite service period (generally the vesting period of the equity grant). For the fiscal year
ended March 31, 2013, the Company recorded share-based compensation expense of $996,000. Share-based
compensation expense recognized in fiscal 2013 is based on awards ultimately expected to vest; therefore, it has
been reduced for estimated forfeitures. ASC Topic 718 requires forfeitures to be estimated at the time of grant and
revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input
assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected
option term, the expected volatility of the Company’s stock over the option’s expected term, the risk-free interest
rate over the option’s term, and the Company’s expected annual dividend yield. The Company’s management
believes that the valuation technique and the approach utilized to develop the underlying assumptions are
appropriate in calculating the fair values of the Company’s stock options granted in fiscal 2013. Estimates of fair
value are not intended to predict actual future events or the value ultimately realized by persons who receive equity
awards.
We do not believe there is a reasonable likelihood there will be a material change in the future estimates or
assumptions we use to determine stock-based compensation expense. However, if actual results are not consistent
with our estimates or assumptions, we may be exposed to changes in stock-based compensation expense that could
be material.
Software Development Costs: Development costs incurred in the research and development of new
software products and enhancements to existing software products for internal use are expensed as incurred until
technological feasibility has been established. After technological feasibility is established, any additional external
software development costs are capitalized and amortized on a straight-line basis over the estimated economic life of
the related product, which is typically five years. The Company performs an annual review of the estimated
economic life and the recoverability of such capitalized software costs. If a determination is made that capitalized
amounts are not recoverable based on the estimated cash flows to be generated from the applicable software, any
remaining capitalized amounts are written off. Although the Company believes that its approach to estimates and
judgments as described herein is reasonable, actual results could differ and the Company may be exposed to
increases or decreases in revenue that could be material.
Recently Issued Accounting Standards
In July 2012, the FASB issued guidance that revises the requirements regarding how entities test indefinite-
lived intangible assets, other than goodwill, for impairment. The guidance allows companies to perform a qualitative
assessment before calculating the fair value of the reporting unit. If entities determine, on the basis of qualitative
factors, that the fair value of the indefinite-lived intangible asset is more likely than not greater than the carrying
amount, a quantitative calculation would not be needed. The guidance becomes effective for the Company at the
beginning of its first quarter of fiscal 2014. The adoption of this guidance does not have a material impact on the
Company’s financial statements.
45
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of CorVel Corporation
We have audited the accompanying consolidated balance sheets of CorVel Corporation (the “Company”) as of March 31,
2012 and 2013, and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the years
ended March 31, 2011, 2012 and 2013. In connection with our audits of the consolidated financial statements, we have also
audited the financial statement schedule for each of the years ended March 31, 2011, 2012, and 2013. We also have audited
CorVel Corporation’s internal control over financial reporting as of March 31, 2013, based on criteria established in Internal
Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
The Company’s management is responsible for these financial statements, for maintaining effective internal control over
financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Report of
Management on Internal Control over Financial Reporting. Our responsibility is to express an opinion on these financial
statements and an opinion on the Company’s internal control over financial reporting based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all
material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management,
and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included
obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and
testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also
included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a
reasonable basis for our opinions.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that
(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions
of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation
of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the
company are being made only in accordance with authorizations of management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s
assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial
position of the Company as of March 31, 2012 and 2013, and the consolidated results of its operations and its cash flows for each
of the years ended March 31, 2011, 2012, and 2013, in conformity with accounting principles generally accepted in the United
States of America. Also, in our opinion, the financial statement schedule for each of the years ended March 31, 2011, 2012, and
2013, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material
respects, the information set forth therein. Also, in our opinion, the Company maintained, in all material respects, effective
internal control over financial reporting as of March 31, 2013, based on criteria established in Internal Control — Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
/s/ HASKELL & WHITE LLP
Irvine, California
June 10, 2013
46
CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
See accompanying notes to consolidated financial statements.
47
201120122013Revenues380,668,000$ 412,668,000$ 429,310,000$ Cost of revenues284,098,000 318,826,000 337,650,000 Gross profit96,570,000 93,842,000 91,660,000 General and administrative 59,167,000 50,405,000 47,765,000 Income before income taxes37,403,000 43,437,000 43,895,000 Income tax provision12,740,000 16,885,000 17,165,000 Net income24,663,000$ 26,552,000$ 26,730,000$ Net income per share:Basic $ 2.09 $ 2.31 $ 2.40 Diluted $ 2.05 $ 2.28 $ 2.38 Weighted average shares outstanding:Basic11,801,000 11,476,000 11,128,000 Diluted12,029,000 11,627,000 11,229,000 Fiscal Years Ended March 31,
CORVEL CORPORATION
CONSOLIDATED BALANCE SHEETS
See accompanying notes to consolidated financial statements.
48
20122013Current AssetsCash and cash equivalents6,597,000$ 19,822,000$ Customer deposits5,816,000 10,107,000 Accounts receivable (less allowance for doubtful accounts of $2,395,000 at March 31, 2012 and $2,295,000 at March 31, 2013)49,334,000 49,105,000 Prepaid expenses and taxes12,263,000 7,418,000 Deferred income taxes, net7,237,000 6,448,000 Total current assets81,247,000 92,900,000 Property and equipment, net47,364,000 46,584,000 Goodwill36,814,000 36,814,000 Other intangible assets, net6,146,000 5,663,000 Non-current deferred income taxes and other assets311,000 421,000 171,882,000$ 182,382,000$ LIABILITIES AND STOCKHOLDERS' EQUITYCurrent LiabilitiesAccounts and taxes payable12,773,000$ 13,587,000$ Accrued liabilities31,989,000 39,168,000 Total current liabilities, net44,762,000 52,755,000 Deferred income taxes16,738,000 18,225,000 Total liabilities61,500,000 70,980,000 Commitments and contingencies (Notes F, H, I, J and L)Stockholders' EquityCommon stock, $.0001 par value: 120,000,000 shares authorized at March 31, 2012 and 2013; 26,261,874 shares issued (11,308,773 shares outstanding, net of Treasury shares) and 26,418,631 shares issued (10,760,124 shares outstanding, net of Treasury shares) at March 31, 2012 and March 31, 2013, respectively3,000 3,000 Paid-in-capital105,907,000 110,924,000 Treasury Stock, at cost (14,953,101 and 15,658,507 shares at March 31, 2012 and 2013, respectively)(270,574,000) (301,301,000) Retained earnings275,046,000 301,776,000 Total stockholders' equity110,382,000 111,402,000 171,882,000$ 182,382,000$ ASSETSMarch 31,
CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Fiscal Years Ended March 31, 2011, 2012, and 2013
See accompanying notes to consolidated financial statements.
49
Common SharesStock AmountPaid-in-CapitalTreasury SharesTreasury StockRetained EarningsTotal Shareholders' EquityBalance -- March 31, 2010 25,801,690 $ 3,000 90,217,000$ (13,775,188) (218,323,000)$ 223,831,000$ 95,728,000$ Stock issued under employee stock purchase plan 7,073 - 317,000 - - - 317,000 Stock issued under stock option plan, net of shares repurchased 313,321 - 4,728,000 - - - 4,728,000 Stock-based compensation expense - - 2,544,000 - - - 2,544,000 Income tax benefits from stock option exercises - - 2,267,000 - - - 2,267,000 Purchase of treasury stock - - - (715,975) (30,608,000) - (30,608,000) Net income - - - - - 24,663,000 24,663,000 Balance -- March 31, 2011 26,122,084 3,000 100,073,000 (14,491,163) (248,931,000) 248,494,000 99,639,000 Stock issued under employee stock purchase plan 8,215 - 321,000 - - - 321,000 Stock issued under stock option plan, net of shares repurchased 131,575 - 2,241,000 - - - 2,241,000 Stock-based compensation expense - - 2,276,000 - - - 2,276,000 Income tax benefits from stock option exercises - - 996,000 - - - 996,000 Purchase of treasury stock - - - (461,938) (21,643,000) - (21,643,000) Net income - - - - - 26,552,000 26,552,000 Balance -- March 31, 2012 26,261,874 3,000 105,907,000 (14,953,101) (270,574,000) 275,046,000 110,382,000 Stock issued under employee stock purchase plan 7,028 - 313,000 - - - 313,000 Stock issued under stock option plan, net of shares repurchased 149,729 - 3,399,000 - - - 3,399,000 Stock-based compensation expense - - 997,000 - - - 997,000 Income tax benefits from stock option exercises - - 308,000 - - - 308,000 Purchase of treasury stock - - - (705,406) (30,727,000) - (30,727,000) Net income - - - - - 26,730,000 26,730,000 Balance -- March 31, 2013 26,418,631 $ 3,000 110,924,000$ (15,658,507) (301,301,000)$ 301,776,000$ 111,402,000$
CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
See accompanying notes to consolidated financial statements.
50
201120122013CASH FLOWS FROM OPERATING ACTIVITIESNet income $ 24,663,000 $ 26,552,000 $ 26,730,000 Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization 12,249,000 14,723,000 15,739,000 Loss on write down or disposal of property or capitalized software 153,000 210,000 412,000 Stock-based compensation expense 2,544,000 2,276,000 996,000 Provision for doubtful accounts 2,437,000 2,146,000 2,123,000 Provision for deferred income taxes 624,000 9,051,000 2,276,000 Changes in operating assets and liabilities:Accounts receivable (7,419,000) (2,516,000) (1,894,000)Customer deposits (3,588,000) (537,000) (4,291,000)Prepaid expenses and taxes 4,000 (5,846,000) 4,845,000 Other assets 298,000 (311,000) (110,000)Accounts and taxes payable 85,000 (1,817,000) 814,000 Accrued liabilities 13,012,000 (8,259,000) 7,179,000 Net cash provided by operating activities 45,062,000 35,672,000 54,819,000 CASH FLOWS FROM INVESTING ACTIVITIESAcquisition of business, net of cash acquired (1,235,000) (45,000) - Purchases of property and equipment (18,504,000) (23,214,000) (14,887,000)Net cash used in investing activities (19,739,000) (23,259,000) (14,887,000)CASH FLOWS FROM FINANCING ACTIVITIESExercise of employee stock purchase options 317,000 321,000 313,000 Exercise of common stock options 4,728,000 2,241,000 3,399,000 Tax benefits from stock options 2,267,000 996,000 308,000 Purchase of treasury stock (30,608,000) (21,643,000) (30,727,000)Net cash used in financing activities (23,296,000) (18,085,000) (26,707,000)Net increase (decrease) in cash and cash equivalents 2,027,000 (5,672,000) 13,225,000 Cash and cash equivalents at beginning of year 10,242,000 12,269,000 6,597,000 CASH AND CASH EQUIVALENTS AT END OF YEAR $ 12,269,000 $ 6,597,000 $ 19,822,000 Supplemental cash flow informationIncome taxes paid $ 13,740,000 $ 12,935,000 $ 9,663,000 Accrual of legal settlement $ 11,100,000 $ - $ - Accrual of software license purchase $ 1,700,000 $ - $ - Fiscal Years Ended March 31,
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note A — Summary of Significant Accounting Policies
Organization: CorVel Corporation (CorVel or the Company), incorporated in Delaware in 1987, provides
services and programs nationwide that are designed to enable insurance carriers, third party administrators and
employers with self-insured programs to administer, manage and control the cost of workers’ compensation and
other healthcare benefits. The Company provides case management, claims administration, and medical bill review
services to these payors.
The Company evaluated all subsequent events or transactions. During the period subsequent to March 31,
2013, the Company repurchased 92,658 shares for $4,511,000 million or an average of $48.67 per share. These
shares were repurchased under the Company’s ongoing share repurchase program described in Note G. The
Company entered into a three year agreement totaling $3.5 million for desktop software licenses, the license period
begins April 1, 2013. On May 17, 2013, the Company announced that its Board of Directors has declared a two-for-
one stock split of the Company’s common stock to be effected in the form of a 100% stock dividend. The stock
dividend will be distributed on June 26, 2013 to stockholders of record on June 12, 2013.
Basis of Presentation: The consolidated financial statements include the accounts of CorVel and its
wholly-owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in
consolidation.
Use of Estimates: The preparation of financial statements in compliance with accounting principles
generally accepted in the United States of America requires management to make estimates and assumptions that
affect the amounts reported in the accompanying financial statements. Actual results could differ from those
estimates. Significant estimates include the values assigned to intangible assets, capitalized software development,
the allowance for doubtful accounts, accrual for income taxes, share-based payments related to performance based
awards, loss contingencies, estimated claims for claims administration revenue recognition, estimates used in stock
options valuations, and accrual for self-insurance reserves.
Cash and Cash Equivalents: Cash and cash equivalents consist of short-term, interest-bearing highly-
liquid investment-grade securities with maturities of 90 days or less when purchased. The carrying amounts of the
Company’s financial instruments approximate their fair values at March 31, 2012 and 2013.
Fair Value of Financial Instruments: The Company applies ASC 820, “Fair Value Measurements and
Disclosures” which defines fair value, establishes framework for measuring fair value, and expands disclosures
about fair value measurements with respect to fair value measurements of (a) nonfinancial assets and liabilities that
are recognized or disclosed at fair value in the Company’s Consolidated Financial Statements on a recurring basis
(at least annually) and (b) all financial assets and liabilities. ASC 820 prioritizes the inputs used in measuring fair
value into the following hierarchy:
Level 1 Quoted market prices in active markets for identical assets or liabilities;
Level 2 Observable inputs other than those included in Level 1 (for example, quoted prices for similar
assets in active markets or quoted prices for identical assets in inactive markets); and
Level 3 Unobservable inputs reflecting management’s own assumptions about the inputs used in estimating
the value of the asset.
The carrying amount of the Company’s financial instruments (i.e. cash, accounts receivable, accounts
payable, etc.) are all Level 1 and approximate their fair values at March 31, 2012 and 2013. The Company has no
Level 2 or Level 3 assets.
CORVEL CORPORATION
51
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note A — Summary of Significant Accounting Policies (continued)
Revenue Recognition: The Company recognizes revenue when there is persuasive evidence of an
arrangement, the services have been provided to the customer, the sales price is fixed or determinable, and
collectability is reasonably assured. For the Company’s services, as the Company’s professional staff performs
work, they are contractually permitted to bill for fees earned in fraction of an hour increments worked or by units of
production. The Company recognizes revenue as the time is worked or as units of production are completed, which
is when the revenue is earned and realized. Labor costs are recognized as the costs are incurred. The Company
derives the majority of its revenue from the sale of Network Solutions and Patient Management services. Network
Solutions and Patient Management services may be sold individually or combined with any of the services the
Company provides. When a sale combines multiple elements, the Company accounts for multiple element
arrangements in accordance with the guidance included in ASC 605-25.
Management evaluates agreements with customers in accordance with the provision of the revenue
recognition topic that addresses multiple-deliverable revenue arrangements. The multiple-deliverable arrangements
entered into consist of bundled managed care which included various units of accounting such as network solutions,
and patient management which includes claims administration. Such elements are considered separate units of
accounting due to each element having value to the customer on a stand-alone basis. The selling price for each unit
of accounting is determined using contract price and management estimates. When the Company’s customers
purchase several products the pricing of the products sold is generally the same as if the product were sold on an
individual basis. Revenue is recognized as the work is performed in accordance with our customer contracts. Based
upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same
accounting period. The Company recognizes revenue for patient management claims administration services over
the life of the customer contract. The Company estimates, based upon prior experience in managing claims, the
deferral amount from when the claim is received to when the customer contract expires.
Accounts Receivable: The majority of the Company’s accounts receivable are due from companies in the
property and casualty insurance industries, self-insured employers and governmental entities. Credit is extended
based on evaluation of a customer’s financial condition and, generally, collateral is not required. Accounts
receivable are generally due within 30 days and are stated at amounts due from customers net of an allowance for
doubtful accounts. Those accounts outstanding longer than the contractual payment terms are considered past due.
The Company determines its allowance by considering a number of factors, including the length of time trade
accounts receivable are past due, the Company’s previous loss history, the customer’s current ability to pay its
obligation to the Company and the condition of the general economy and the industry as a whole. The Company
writes off accounts receivable, along with sales adjustments, to cost of revenues when they become uncollectible.
Accounts receivable includes $5,775,000 and $5,221,000 of unbilled receivables at March 31, 2012 and 2013,
respectively. Unbilled receivables represent the revenue for the work performed which has not yet been invoiced to
the customer. Unbilled receivables are generally invoiced within the following month.
Concentrations of Credit Risk: Substantially all of the Company’s customers are payors of workers’
compensation expense and property and casualty insurance, which include insurance companies, third party
administrators, self-insured employers and government entities. Receivables are generally due within 30 days.
Credit losses relating to customers in the workers’ compensation insurance industry consistently have been within
management’s expectations. Virtually all of the Company’s cash is invested at financial institutions in amounts
which exceed the FDIC insurance levels. No customer accounted for 10% or more of revenue for either fiscal 2011,
2012, or 2013. No customer accounted for 10% or more of accounts receivable at either March 31, 2012 or 2013.
52
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note A — Summary of Significant Accounting Policies (Continued)
Property and Equipment: Additions to property and equipment are recorded at cost. The Company
provides for depreciation on property and equipment using the straight-line method by charges to operations in
amounts that allocate the cost of depreciable assets over their estimated lives as follows:
Asset Classification
Leasehold Improvements
Furniture and Equipment
Computer Hardware
Computer Software
Mobile Computing Devices
Estimated Useful Life
The shorter of five years or the life of lease
Five to seven years
Three to five years
Three to five years
One year
The Company accounts for internally developed software costs in accordance with ASC 350-40, “Internal –
Use Software”. Capitalized software development costs, intended for internal use, totaled $16,598,000 (net of
$41,647,000 in accumulated amortization) and $18,726,000 (net of $47,178,000 in accumulated amortization), as of
March 31, 2012 and 2013, respectively. These costs are included in computer software in property and equipment
and are amortized over a period of five years.
Long-Lived Assets: The carrying amount of all long-lived assets is evaluated periodically to determine if
adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation
is based principally on the expected utilization of the long-lived assets and the projected, undiscounted cash flows of
the operations in which the long-lived assets are deployed.
Goodwill and Long-Lived Assets: The Company accounts for its business combinations in accordance with
the Financial Accounting Standards Board (“FASB”) ASC 805-10 through ASC 805-50 Business Combinations
which requires that the purchase method of accounting be applied to all business combinations and addresses the
criteria for initial recognition of intangible assets and goodwill. In accordance with FASB ASC 350-10 through ASC
350-30, goodwill and other intangible assets with indefinite lives are not amortized but are tested for impairment
annually, or more frequently if circumstances indicate the possibility of impairment. If the carrying value of
goodwill or an intangible asset exceeds its fair value, an impairment loss shall be recognized. Based on the
Company’s tests and reviews, no impairment of its goodwill, intangible assets or other long-lived assets existed at
March 31, 2013. However, future events or changes in current circumstances could affect the recoverability of the
carrying value of goodwill and long-lived assets. Should an asset be deemed impaired, an impairment loss would be
recognized to the extent the carrying value of the asset exceeded its estimated fair value. Goodwill amounted to
$36,814,000 (net of accumulated amortization of $2,069,000) at March 31, 2012 and at March 31, 2013.
Cost of revenues: Cost of services consists primarily of the compensation and fringe benefits of field
personnel, including managers, medical bill analysts, field case managers, telephonic case managers, systems
support, administrative support and account managers and account executives and related facility costs including
rent, telephone and office supplies. Historically, the costs associated with these additional personnel and facilities
have been the most significant factor driving increases in the Company’s cost of services.
53
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note A — Summary of Significant Accounting Policies (Continued)
Income Taxes: The Company provides for income taxes in accordance with provisions specified in ASC
740, “Accounting for Income Taxes”. Accordingly, deferred income tax assets and liabilities are computed for
differences between the financial statement and tax bases of assets and liabilities. These differences will result in
taxable or deductible amounts in the future, based on tax laws and rates applicable to the periods in which the
differences are expected to affect taxable income. The ultimate realization of deferred tax assets is dependent upon
the generation of future taxable income during the periods in which temporary differences become deductible. In
making an assessment regarding the probability of realizing a benefit from these deductible differences,
management considers the Company’s current and past performance, the market environment in which the Company
operates, tax-planning strategies and the length of carry-forward periods for loss carry-forwards, if any. Valuation
allowances are established when necessary to reduce deferred tax assets to amounts that are more likely than not to
be realized. Further, the Company provides for income tax issues not yet resolved with federal, state and local tax
authorities.
Share-Based Compensation: The Company accounts for share-based compensation in accordance with the
provisions of ASC Topic 718 “Compensation – Stock Compensation”. Under ASC 718, share-based compensation
cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense
over the employee’s requisite service period (generally the vesting period of the equity grant). For the fiscal years
ended March 31, 2011, 2012, and 2013, the Company recorded share-based compensation expense of $2,544,000,
$2,276,000, and $996,000, respectively. Share-based compensation expense is based on awards ultimately expected
to vest; therefore, it has been reduced for estimated forfeitures. ASC Topic 718 requires forfeitures to be estimated
at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
Accrual for Self-insurance Costs: The Company self-insures for the group medical costs and workers’
compensation costs of its employees. The Company purchases stop loss insurance for large claims. Management
believes that the self-insurance reserves are appropriate; however, actual claims costs may differ from the original
estimates requiring adjustments to the reserves. The Company determines its estimated self-insurance reserves
based upon historical trends along with outstanding claims information provided by its claims paying agents.
Earnings Per Share: Earnings per common share-basic is based on the weighted average number of
common shares outstanding during the period. Earnings per common shares-diluted is based on the weighted
average number of common shares and common share equivalents outstanding during the period. In calculating
earnings per share, earnings are the same for the basic and diluted calculations. Weighted average shares outstanding
is greater for diluted earnings per share due to the effect of stock options.
The difference between the basic shares and the diluted shares for each of the three fiscal years ended
March 31, 2011, 2012, and 2013 is as follows:
54
Fiscal 2011Fiscal 2012Fiscal 2013Basic weighted shares11,801,00011,476,00011,128,000Treasury stock impact of stock options228,000151,000101,000Diluted weighted shares12,029,00011,627,00011,229,000
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note A — Summary of Significant Accounting Policies (continued)
Recently Issued Accounting Standards
In July 2012, the FASB issued guidance that revises the requirements regarding how entities test indefinite-
lived intangible assets, other than goodwill, for impairment. The guidance allows companies to perform a qualitative
assessment before calculating the fair value of the reporting unit. If entities determine, on the basis of qualitative
factors, that the fair value of the indefinite-lived intangible asset is more likely than not greater than the carrying
amount, a quantitative calculation would not be needed. The guidance becomes effective for the Company at the
beginning of its first quarter of fiscal 2014. The adoption of this guidance does not have a material impact on the
Company’s financial statements.
Note B — Stock Options and Stock-Based Compensation
Under the Company’s Restated Omnibus Incentive Plan (Formerly The Restated 1988 Executive Stock
Option Plan) (“the Plan”) as in effect at March 31, 2013, options for up to 9,682,500 shares of the Company’s
common stock may be granted over the life of the Plan to key employees, non-employee directors and consultants at
exercise prices not less than the fair market value of the stock at the date of grant. Options granted under the Plan are
non-statutory stock options and generally vest 25% one year from date of grant and the remaining 75% vesting
ratably each month for the next 36 months. The options granted to employees and the board of directors expires at
the end of five years and ten years from date of grant, respectively.
The Company records compensation expense for employee stock options based on the estimated fair value
of the options on the date of grant using the Black-Scholes option-pricing model with the assumptions included in
the table below. The Company uses historical data among other factors to estimate the expected volatility, the
expected option life, and the expected forfeiture rate. The risk-free rate is based on the interest rate paid on a U.S.
Treasury issue with a term similar to the estimated life of the option. During fiscal 2013, based upon the historical
experience of option cancellations, the Company has an estimated annualized forfeiture rate of 12.8%. Forfeiture
rates will be adjusted over the requisite service period when actual forfeitures differ, or are expected to differ, from
the estimate.
The fair value of each grant is estimated on the date of grant using the Black-Scholes option-pricing model.
The following weighted average assumptions were used for fiscal years ended March 31, 2011, 2012 and 2013:
55
Fiscal 2011Fiscal 2012Fiscal 2013Expected volatility46% to 47%46% to 47%47%Risk free interest rate1.5% to 2.2%0.7% to 1.9%0.6% to 0.8%Dividend yield0.0%0.0%0.0%Weighted average option life4.8 to 5.0 years4.6 to 5.0 years4.5 years
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note B — Stock Options and Stock-Based Compensation (continued)
For the fiscal years ended March 31, 2011, 2012 and 2013, the Company recorded share-based
compensation expense of $2,544,000, $2,276,000, and $996,000, respectively. The table below shows the amounts
recognized in the financial statements for the fiscal years ended March 31, 2011, 2012 and 2013.
All options granted in the three fiscal years ended March 31, 2011, 2012, and 2013 were granted at fair
value and are non-statutory stock options. Summarized information for all stock options for the past three fiscal
year follows:
56
Fiscal 2011 Fiscal 2012 Fiscal 2013 Cost of revenue $ 608,000 $ 484,000 $ 461,000 General and administrative 1,936,000 1,792,000 535,000 2,544,000 2,276,000 996,000 Amount of income tax benefit recognized 986,000 897,000 395,000 Amount charged to net income $ 1,558,000 $ 1,379,000 $ 601,000 Effect on basic earnings per share $ 0.13 $ 0.12 $ 0.05 Effect on diluted earnings per share $ 0.13 $ 0.12 $ 0.05 Total cost of stock-based compensation included in income before income taxFiscal 2011Fiscal 2012Fiscal 2013Options outstanding - beginning of the year1,065,403813,662751,023Options granted207,325149,075123,100Options exercised(371,057)(173,064)(174,045)Options cancelled/forfeited(88,009)(38,650)(149,602)Options outstanding – end of year813,662751,023550,476During the year, weighted average exercise price of:Options granted $ 42.40 $ 50.43 $ 46.08 Options exercised $ 20.16 $ 25.00 $ 25.59 Options forfeited $ 17.53 $ 34.09 $ 42.52 At the end of the yearPrice range of outstanding options$11.00-$47.70$15.50-$52.76$15.55-$52.76Weighted average exercise price per share$29.26 $34.19 $37.31 Options available for future grants726,410616,026642,528Exercisable options374,141388,154278,962
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note B — Stock Options and Stock-Based Compensation (continued)
The following table summarizes the status of stock options outstanding and exercisable at March 31, 2013:
A summary of the status for all outstanding options at March 31, 2013, and changes during the fiscal year
then ended is presented in the table below:
57
Range of Exercise PricesNumber of Outstanding OptionsWeighted Average Remaining Contractual LifeOutstanding Options -- Weighted Average Exercise PriceExercisable Options -- Number of Exercisable OptionsExercisable Options -- Weighted Average Exercise Price$15.55 to $26.85132,8222.50$20.92 121,623$20.72 $26.86 to $40.16148,0002.7133.67117,87032.77 $40.17 to $46.70138,9814.6944.6628,29245.42 $46.71to $52.76130,6734.1850.2811,17750.55 Total 550,4763.51$37.31 278,962$29.51 Number of OptionsWeighted Average Exercise Price per ShareWeighted Average Remaining Contractual Life (Years)Aggregate Intrinsic Value as of March 31, 2013Options outstanding, March 31, 2012 751,023 $34.19 Granted 123,100 46.08 Exercised (174,045)25.59 Cancelled – forfeited (77,909)42.54 Cancelled – expired(71,693)42.49Options outstanding, March 31, 2013550,476$37.31 3.51$6,871,264 Options vested and expected to vest488,743$36.00 3.35$6,722,829 Ending exercisable278,962$29.51 2.64$5,585,463
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note B — Stock Options and Stock-Based Compensation (continued)
The weighted average fair value of options granted during fiscal 2011, 2012, and 2013 was $17.41, $20.68,
and $18.60, respectively. The total intrinsic value of options exercised during fiscal years 2011, 2012, and 2013
were $9,173,000, $4,148,000, and $3,388,000 respectively.
Included in the above-noted stock option grants and stock compensation expense are performance based
stock options whereas vesting occurs only upon the Company achieving certain revenue or earnings per shares
targets as determined by the Company’s board of directors. The options were valued in the same manner as the
time vesting options. However, the Company only recognizes stock compensation to the extent that the targets are
probable which allow the options to vest. During fiscal years ended March 31, 2011, 2012 and 2013, the Company
recognized stock compensation expense in the amount of $1,144,000, $1,002,000, and $0, respectively.
The Company received $4,728,000, $2,241,000, and $3,399,000 of cash receipts from the exercise of stock
options during fiscal 2011, 2012, and 2013, respectively. Vested options at March 31, 2013 were 278,962.
Unvested options at March 31, 2013 were 271,514. As of March 31, 2013, $2,147,000 of total unrecognized
compensation costs related to stock options is expected to be recognized over a weighted average period of 3.2
years.
Note C — Property and Equipment
Property and equipment, net consisted of the following at March 31, 2012 and 2013:
58
20122013Computer software $71,108,000 $79,257,000 Office equipment and computers 62,366,00059,953,000Leasehold improvements 4,987,0004,925,000138,461,000144,135,000Less: accumulated depreciation and amortization (91,097,000)(97,551,000)$47,364,000 $46,584,000
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note D — Accounts and Taxes Payable and Accrued Liabilities
Accounts and income taxes payable consisted of the following at March 31, 2012 and 2013:
Accounts payable
Income taxes payable
2012
$11,614,000
1,159,000
$12,773,000
2013
$ 12,559,000
1,028,000
$13,587,000
Accrued liabilities consisted of the following at March 31, 2012 and 2013:
59
20122013Payroll, payroll taxes and employee benefits$13,575,000 $14,855,000 Accrued professional service fees9,473,00013,570,000Self-insurance accruals3,370,0003,425,000Deferred revenue2,779,0004,246,000Accrued rent2,024,0002,291,000Accrued legal settlements408,000280,000Other360,000501,000$31,989,000 $39,168,000
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note E — Income Taxes
The income tax provision consisted of the following for the three fiscal years ended March 31, 2011, 2012
and 2013:
The following is a reconciliation of the income tax provision from the statutory federal income tax rate to
the effective rate for the three fiscal years ended March 31, 2011, 2012 and 2013:
Income taxes paid totaled $13,740,000, $12,935,000, and $9,663,000 for the fiscal years ended March 31,
2011, 2012, and 2013, respectively.
60
201120122013Current — Federal $ 8,888,000 $ 5,896,000 $ 12,214,000 Current — State 3,228,000 1,938,000 3,653,000 Subtotal 12,116,000 7,834,000 15,867,000 Deferred — Federal 1,136,000 8,104,000 1,332,000 Deferred — State (512,000) 947,000 (34,000) Subtotal 624,000 9,051,000 1,298,000 $ 12,740,000 $ 16,885,000 $ 17,165,000 201120122013Income taxes at federal statutory rate (35%) $ 13,091,000 $ 15,203,000 $ 15,363,000 State income taxes, net of federal benefit 1,772,000 1,615,000 1,172,000 FIN 48 benefit (1,649,000) 26,000 26,000 Other (474,000) 41,000 604,000 $ 12,740,000 $ 16,885,000 $ 17,165,000
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note E — Income Taxes (continued)
Deferred tax assets and liabilities at March 31, 2012 and 2013 are:
Prepaid expenses and taxes include $7,909,000 and $2,833,000 at March 31, 2012 and 2013, respectively,
for income taxes due in the first quarter of the succeeding fiscal year.
\
61
20122013Deferred income tax assets:Accrued liabilities not currently deductible $ 5,123,000 $ 5,075,000 Allowance for doubtful accounts 958,000 918,000 FIN 48 income tax benefits - - Stock-based compensation 1,605,000 925,000 Other 1,760,000 805,000 Deferred assets 9,446,000 7,723,000 Deferred income tax liabilities:Excess of book over tax basis of fixed assets (14,220,000) (14,277,000)Intangible assets (4,256,000) (4,728,000)Other (471,000) (495,000)Deferred liabilities (18,947,000) (19,500,000)Net deferred tax asset/(liability) $(9,501,000) $(11,777,000)
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note E — Income Taxes (continued)
In July 2006, the FASB issued guidance which prescribes a recognition threshold and measurement
attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in
a tax return. The Company adopted this guidance effective April 1, 2007, and recognized a $2,700,461 increase in
the liability for unrecognized tax benefits. A reconciliation of the beginning and ending amount of unrecognized tax
benefits is as follows:
Balance as of March 31, 2012
Additions based on tax positions related to the current year
Additions for tax positions of prior years
Reductions for tax positions of prior years
Balance as of March 31, 2013
$ 983,000
111,000
167,000
(489,000)
$ 772,000
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.
During the fiscal years ended March 31, 2011, 2012 and 2013, the Company recognized approximately
$(1,270,000), ($396,000) and $80,000 in interest and penalties, respectively. As of March 31, 2011, 2012 and 2013,
accrued interest and penalties related to uncertain tax positions were $572,000, $176,000 and $257,000,
respectively.
The Company believes there will be a material reduction in its unrecognized tax benefits within the next
12 months due to settlements with various tax jurisdictions.
The tax fiscal years 2009-2012 remain open to examination by the major taxing jurisdictions to which the
Company is subject.
Note F— Employee Stock Purchase Plan
The Company maintains an Employee Stock Purchase Plan (“ESPP”) which allows employees of the
Company and its subsidiaries to purchase shares of common stock on the last day of two six-month purchase periods
(i.e. March 31 and September 30) at a purchase price which is 95% of the closing sale price of shares as quoted on
NASDAQ on the last day of such purchase period. Employees are allowed to contribute up to 20% of their gross
pay. A maximum of 1,425,000 shares has been authorized for issuance under the ESPP, as amended. As of March
31, 2013, 1,209,257 had been issued pursuant to the ESPP. Summarized ESPP information is as follows:
62
201120122013Employee contributions $ 317,000 $ 321,000 $ 313,000 Shares acquired 7,073 8,215 7,028 Average purchase price $ 44.83 $ 39.07 $ 44.60
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note G — Treasury Stock
During each of the three fiscal years in the period ended March 31, 2013, the Company continued to
repurchase shares of its common stock under a plan originally approved by the Company’s Board of Directors in
1996. Including a 1,000,000 share expansion authorized in February 2012, the total number of shares authorized to
be repurchased over the life of the plan is 16,000,000 shares. Purchases may be made from time to time depending
on market conditions and other relevant factors. The share repurchases for fiscal years ended March 31, 2011, 2012
and 2013 and cumulatively since inception of the authorization are as follows:
During the period subsequent to March 31, 2013, the Company repurchased 92,658 shares for $4.5 million
or an average of $48.67 per share. The repurchased shares were recorded as treasury stock, at cost, and are available
for general corporate purposes. The repurchases were primarily financed from cash generated from operations and
from the cash proceeds from the exercise of stock options.
Note H — Commitments
The Company leases office facilities under non-cancelable operating leases. Some of these leases contain
escalation clauses. Future minimum rental commitments under operating leases at March 31, 2013 are $13,527,000
in fiscal 2014, $11,955,000 in fiscal 2015, $9,539,000 in fiscal 2016, $6,643,000 in fiscal 2017, $3,814,000 in fiscal
2018, $2,319,000 thereafter, and $47,797,000 in the aggregate. Total rental expense of $14,620,000, $14,949,000,
and $13,951,000 was charged to operations for the years ended March 31, 2011, 2012, and 2013, respectively.
Note I — Contingencies and Legal Proceedings
The Company is involved in litigation arising in the normal course of business. Management believes that
resolution of these matters will not result in any payment that, in the aggregate, would be material to the financial
position or results of the operations of the Company.
Note J — Retirement Savings Plan
The Company maintains a retirement savings plan for its employees, which is a qualified plan under
Section 401(k) of the Internal Revenue Code. Full-time employees that meet certain requirements are eligible to
participate in the plan. Employer contributions are made annually, primarily at the discretion of the Company’s
Board of Directors. Contributions of $273,000, $347,000 and $372,000 were charged to operations for the fiscal
years ended March 31, 2011, 2012, and 2013, respectively.
63
201120122013Cumulative Shares repurchased 715,975 461,938 705,406 15,658,507 Cost $ 30,608,000 $ 21,643,000 $ 30,727,000 $ 301,301,000 Average price $ 42.75 $ 46.85 $ 43.56 $ 19.24
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note K — Shareholder Rights Plan
During fiscal 1997, the Company’s Board of Directors approved the adoption of a Shareholder Rights Plan.
The Shareholder Rights Plan provides for a dividend distribution to CorVel stockholders of one preferred stock
purchase right for each outstanding share of CorVel’s common stock under certain circumstances. In April 2002,
the Board of Directors of CorVel approved an amendment to the Shareholder Rights Plan to extend the expiration
date of the rights to February 10, 2012, set the exercise price of each right at $118, and enable Fidelity Management
& Research Company and its affiliates to purchase up to 18% of the shares of common stock of the Company
without triggering the stockholder rights, with the limitations under the Shareholder Rights Plan remaining in effect
for all other stockholders of the Company. In November 2008, the Company’s Board of Directors approved an
amendment to the Shareholder Rights Plan to extend the expiration date of the rights to February 10, 2022, remove
the ability of Fidelity Management & Research Company and its affiliates to purchase up to 18% of the shares of
common stock of the Company without triggering the stockholder rights, substitute Computershare Trust Company,
N.A. as the rights agent and effect certain technical changes to the Shareholder Rights Plan.
Generally, the Shareholder Rights Plan provides that if a person or group acquires 15% or more of the
Company’s common stock without the approval of the Board, subject to certain exceptions, the holders of the rights,
other than the acquiring person or group, would, under certain circumstances, have the right to purchase additional
shares of the Company’s common stock having a market value equal to two times the then-current exercise price of
the right. In addition, if the Company is thereafter merged into another entity, or if 50% or more of the Company’s
consolidated assets or earning power are sold, then the right will entitle its holder to buy common shares of the
acquiring entity having a market value equal to two times the then-current exercise price of the right. The
Company’s Board of Directors may exchange or redeem the rights under certain conditions.
Note L — Line of Credit
In September 2012, the Company renewed a line of credit agreement. The line is with a financial
institution to provide a revolving credit facility with borrowing capacity of up to $10 million. Borrowings under this
agreement bear interest, at the Company’s option, at a fixed LIBOR-based rate plus 1.50% or at a fluctuating rate
determined by the financial institution to be 1.50% above the daily one-month LIBOR rate. The loan covenants
require the Company to maintain the current assets to liabilities ratio of at least 1.25:1, debt to tangible net worth not
greater than 1.25:1 and have positive net income. There were no outstanding revolving loans at any time during
fiscal 2013 or as of the date hereof, but letters of credit in the aggregate amount of $8.0 million have been issued
separate from the line of credit and therefore do not reduce the amount of borrowings available under the revolving
credit facility. The renewed credit agreement expires in September 2013.
64
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note M — Quarterly Results (Unaudited)
The following is a summary of unaudited quarterly results of operations for each of the quarters in the two
fiscal years ended March 31, 2012 and 2013:
65
Revenues Gross ProfitNet Income Net Income per Basic Common ShareNet Income per Diluted Common ShareFiscal Year Ended March 31, 2012:First Quarter $102,307,000$25,544,000$8,198,000$0.71 $0.70 Second Quarter 104,552,00025,612,0007,881,000 0.68 0.68 Third Quarter 101,382,00021,226,0005,400,000 0.47 0.47 Fourth Quarter 104,427,00021,460,0005,073,000 0.45 0.44 Fiscal Year Ended March 31, 2013:First Quarter $104,606,000$23,181,000$6,596,000$0.58 $0.58 Second Quarter 105,458,00022,836,0006,630,000 0.59 0.58 Third Quarter 107,287,00021,734,0005,924,000 0.53 0.53 Fourth Quarter 111,959,00023,909,0007,580,000 0.70 0.70
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note N — Segment Reporting
The Company derives the majority of its revenues from providing patient management and network
solutions services to payors of workers’ compensation benefits, automobile insurance claims and health insurance
benefits. Patient management services include claims administration, utilization review, medical case management,
and vocational rehabilitation. Network solutions revenues include fee schedule auditing, hospital bill auditing,
coordination of independent medical examinations, diagnostic imaging review services and preferred provider
referral services. The percentages of revenues attributable to patient management and network solutions services for
the fiscal years ended March 31, 2011, 2012, and 2013 are listed below.
The Company’s management is structured geographically with regional vice-presidents who report to the
Executive Vice-President of the Company who reports to the Chief Executive Officer of the Company. Each of
these regional vice-presidents is responsible for all services provided by the Company in his or her particular region
and responsible for the operating results of the Company in multiple states. These regional vice presidents have area
and district managers who are also responsible for all services provided by the Company in their given area and
district.
Under FASB ASC 280-10, two or more operating segments may be aggregated into a single operating
segment for financial reporting purposes if aggregation is consistent with the objective and basic principles, if the
segments have similar economic characteristics, and if the segments are similar in each of the following areas:: 1)
the nature of products and services; 2) the nature of the production processes; 3) the type or class of customer for
their products and services; and 4) the methods used to distribute their products or provide their services. The
Company believes each of the Company’s regions meet these criteria as they provide similar managed care services
to similar customers using similar methods of productions and similar methods to distribute their services. All of the
Company’s regions perform both patient management and network solutions services.
Because the Company believes it meets each of the criteria set forth above and each of the Company’s
regions has similar economic characteristics, the Company aggregates its results of operations in one reportable
operating segment.
66
201120122013Patient management services47.0%49.3%51.5%Network solutions services53.0%50.7%48.5%100.0%100.0%100.0%
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2011, 2012 and 2013
Note O — Other Intangible Assets
Other intangible assets consist of the following at March 31, 2012:
Item
Covenant Not to Compete
Customer relationships
TPA Licenses
Total
Life
5 years
18-20 years
15 years
Cost
$775,000
7,922,000
204,000
$8,901,000
Fiscal 2012
Amortization
Expense
$147,000
423,000
14,000
$584,000
Accumulated
Amortization
at March 31,
2012
$661,000
2,031,000
63,000
$2,755,000
Cost, Net of
Accumulated
Amortization at
March 31, 2012
$114,000
5,891,000
141,000
$6,146,000
Other intangible assets consist of the following at March 31, 2013:
Amortization expense for the next five fiscal years is expected to be $451,000 in fiscal 2014, $437,000 in
fiscal 2015, $437,000 in fiscal 2016, $437,000 in fiscal 2017, $437,000 in fiscal 2018, and $3,390,000 thereafter.
67
Item Life Cost Fiscal 2013 Amortization Expense Accumulated Amortization at March 31, 2013 Cost, Net of Accumulated Amortization at March 31, 2013 Covenant Not to Compete 5 years $ 775,000 $ 47,000 $ 708,000 $ 67,000 Customer Relationships 18-20 years 7,922,000 423,000 2,453,000 5,469,000 TPA Licenses 15 years 204,000 14,000 77,000 127,000 Total $ 8,901,000 $ 484,000 $ 3,238,000 $ 5,663,000
Exhibit
No.
3.1
3.2
10.1*
10.2*
10.3*
10.4*
10.5*
EXHIBIT INDEX
Amended and Restated Certificate of Incorporation of the Company - - Incorporated herein by
reference to Exhibit 3.1 to the Current Report on Form 8-K filed on August 10, 2011.
Title - - Method of Filing
Page
Amended and Restated Bylaws of the Company - - Incorporated herein by reference to Exhibit
3.2 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30,
2006 filed on August 14, 2006.
Nonqualified Stock Option Agreement between V. Gordon Clemons, the Company and North
Star together with all amendments and addendums thereto - - Incorporated herein by reference to
Exhibit 10.6 to the Company’s Registration Statement on Form S-1 Registration No. 33-40629
initially filed on May 16, 1991.
Supplementary Agreement between V. Gordon Clemons, the Company and North Star - -
Incorporated herein by reference to Exhibit 10.7 to the Company’s Registration Statement on
Form S-1 Registration No. 33-40629 initially filed on May 16, 1991.
Amendment to Supplementary Agreement between Mr. Clemons, the Company and North Star -
- Incorporated herein by reference to Exhibit 10.5 to the Company’s Annual Report on Form 10-
K for the fiscal year ended March 31, 1992 filed on June 29, 1992.
Restated Omnibus Incentive Plan (Formerly The Restated 1988 Executive Stock Option Plan) - -
Incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K
field on August 10, 2011.
Forms of Notice of Grant of Stock Option, Stock Option Agreement and Notice of Exercise
Under the Restated Omnibus Incentive Plan (Formerly The Restated 1988 Executive Stock
Option) - - Incorporated herein by reference to Exhibit 10.2 to the Company’s Quarterly Report
on Form 10-Q for the quarterly period ended September 30, 2006 filed on November 9, 2006,
Exhibits 10.7, 10.8 and 10.9 to the Company’s Annual Report on Form 10-K for the fiscal year
ended March 31, 1994 filed on June 29, 1994, Exhibits 99.2, 99.3, 99.4, 99.5, 99.6, 99.7 and
99.8 to the Company’s Registration Statement on Form S-8 (File No. 333-94440) filed on July
10, 1995, and Exhibits 99.3 and 99.5 to the Company’s Registration Statement on Form S-8
(File No. 333-58455) filed on July 2, 1998.
10.6*
Employment Agreement of V. Gordon Clemons - - Incorporated herein by reference to Exhibit
10.12 to the Company’s Registration Statement on Form S-1 Registration No. 33-40629 initially
filed on May 16, 1991.
68
Exhibit
No.
10.7*
10.8
10.9
10.10*
10.11*
10.12†
EXHIBIT INDEX (continued)
Title - - Method of Filing
Restated 1991 Employee Stock Purchase Plan, as amended - - Incorporated herein by reference
to Exhibit 10.1 to the Company’s Current Report on Form 8-K/A filed on August 12, 2010.
Fidelity Master Plan for Savings and Investment, and amendments - - Incorporated herein by
reference to Exhibits 10.16 and 10.16A to the Company’s Registration Statement on Form S-1
Registration No. 33-40629 initially filed on May 16, 1991.
Second Amended and Restated Preferred Shares Rights Agreement, dated as of November 17,
2008, by and between CorVel Corporation and and Computershare Trust Company, N.A.,
including the original Certificate of Designation, the Certificate of Designation Increasing the
Number of Shares, the form of Right Certificate (as amended) and the Summary of Rights (as
amended) attached thereto as Exhibits A-1, A-2, A-3, B and C, respectively. Incorporated
herein by reference to Exhibit 4.1 to the Company’s Form 8-K filed on November 24, 2008.
Employment Agreement effective May 26, 2006 by and between CorVel Corporation and Dan
Starck - - Incorporated herein by reference to Exhibit 10.1 in the Company’s Form 8-K filed on
May 30, 2006.
Stock Option Agreement and Acceleration Addendum dated May 26, 2006 by and between
CorVel Corporation and Dan Starck, providing for time vesting. - -Incorporated herein by
reference to Exhibit 10.2 in the Company’s Form 8-K filed on May 30, 2006.
Stock Option Agreement and Acceleration Addendum dated May 26, 2006 by and between
CorVel Corporation and Dan Starck, providing for performance vesting. - - Incorporated herein
by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on May 30,
2006.
10.13†
Stock Option Agreement dated May 26, 2006 by and between CorVel Corporation and Scott
McCloud, providing for performance vesting. - - Incorporated herein by reference to Exhibit
10.1 to the Company’s Current Report on Form 8-K filed on June 2, 2006.
10.14*†
Stock Option Agreement dated May 26, 2006 by and between CorVel Corporation and Don
McFarlane, providing for performance vesting. - - Incorporated herein by reference to Exhibit
10.15 to the Company’s Annual Report on Form 10-K/A filed on July 6, 2007.
10.15
Credit Agreement dated May 28, 2009 by and between CorVel Corporation and Wells Fargo
Bank, National Association. - - Incorporated herein by reference to Exhibit 10.16 to the
Company’s Current Report on Form 8-K filed on June 4, 2009.
69
Exhibit
No.
10.16
10.17
10.18*†
10.19*†
10.20*†
EXHIBIT INDEX (continued)
Title - - Method of Filing
Revolving Line of Credit Note dated May 28, 2009 by CorVel Corporation in favor of Wells
Fargo Bank, National Association. - - Incorporated herein by reference to Exhibit 10.17 to the
Company’s Current Report on Form 8-K filed on June 4, 2009.
Form of Partial Waiver of Automatic Option Grant executed by Directors - -Incorporated herein
by reference to Exhibit 10.18 to the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended September 30, 2007 filed on November 8, 2007.
Stock Option Agreement and Acceleration Addendum dated February 4, 2008 by and between
CorVel Corporation and Dan Starck, providing for performance vesting. - - Incorporated herein
by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K for the fiscal year
ended March 31, 2008 filed on June 16, 2008.
Stock Option Agreement dated February 4, 2008 by and between CorVel Corporation and Scott
McCloud, providing for performance vesting. - - Incorporated herein by reference to Exhibit
10.20 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2008
filed on June 16, 2008.
Stock Option Agreement dated February 4, 2008 by and between CorVel Corporation and Don
McFarlane, providing for performance vesting. - Incorporated herein by reference to Exhibit
10.21 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2008
filed on June 16, 2008.
10.21
Partial Waiver of Automatic Option Grant by Jean Macino dated February 8, 2008 - -
Incorporated herein by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-
K for the fiscal year ended March 31, 2008 filed on June 16, 2008.
10.22*†
Stock Option Agreement dated February 24, 2009 by and between CorVel Corporation and
Daniel J. Starck, providing for performance vesting. - - Incorporated herein by reference to
Exhibit 10.1 to the Company’s Form 8-K filed on March 2, 2009.
10.23*†
Stock Option Agreement dated February 24, 2009 by and between CorVel Corporation and Scott
R. McCloud, providing for performance vesting. - - Incorporated herein by reference to Exhibit
10.2 to the Company’s Form 8-K filed on March 2, 2009.
10.24*†
Stock Option Agreement dated February 24, 2009 by and between CorVel Corporation and
Donald C. McFarlane, providing for performance vesting. - - Incorporated herein by reference to
Exhibit 10.3 to the Company’s Form 8-K filed on March 2, 2009.
70
EXHIBIT INDEX (continued)
Exhibit
No.
Title - - Method of Filing
10.25*† Stock Option Agreement dated February 5, 2009 by and between CorVel Corporation
and Diane J. Blaha, providing for performance vesting. Incorporated herein by
reference to Exhibit 10.25 to the Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 2009 filed on June 12, 2009.
10.26*† Stock Option Agreement dated February 24, 2009 by and between CorVel Corporation
and Diane J. Blaha, providing for performance vesting. Incorporated herein by reference
to Exhibit 10.26 to the Company’s Annual Report on Form 10-K for the fiscal year
ended March 31, 2009 filed on June 12, 2009.
10.27*† Summary of Terms of Oral Agreement to Repurchase Shares of Common Stock held by
V. Gordon Clemons. Incorporated herein by reference to Exhibit 10.1 to the Company’s
Quarterly Report on Form 10-Q for the quarter ended December 31, 2009 filed on
February 8, 2010
10.28*†
Stock Option Agreement granted November 2, 2009 by and between CorVel
Corporation and Daniel J. Starck, providing for performance vesting. Refiled herewith.
10.29*†
Stock Option Agreement granted November 2, 2009 by and between CorVel
Corporation and Scott R. McCloud, providing for performance vesting. Refiled
herewith.
10.30*† Stock Option Agreement granted November 2, 2009 by and between CorVel
Corporation and Donald C. McFarlane, providing for performance vesting. Refiled
herewith.
71
Exhibit
No.
31.1
31.2
32.1
32.2
101.0
EXHIBIT INDEX (continued)
Title - - Method of Filing
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-
Oxley Act of 2002. - - Filed herewith.
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-
Oxley Act of 2002. - - Filed herewith.
Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. - - Furnished
herewith.
Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. – Furnished
herewith.
The following materials from CorVel Corporation's Annual Report on Form 10-K for
the fiscal year ended March 31, 2012, formatted in XBRL (eXtensible Business
Reporting Language): (i) Consolidated Balance Sheets as of March 31, 2012 and March
31, 2011; (ii) Consolidated Statements of Income for the fiscal years ended March 31,
2012, 2011 and 2010; (iii) Consolidated Statements of Stockholders' Equity for the
fiscal years ended March 31, 2012, 2011 and 2010; (iv) Consolidated Statements of
Cash Flows for the fiscal years ended March 31, 2012, 2011 and 2010; and (v) Notes to
Consolidated Financial Statements(**)
* - Denotes management contract or compensatory plan or arrangement.
** - Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101.0 hereto are deemed not
filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933,
as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as
amended, and otherwise are not subject to liability under those sections.
† - Confidential treatment has been requested for certain confidential portions of this exhibit pursuant to Rule 24b-2
under the Securities Exchange Act of 1934. In accordance with Rule 24b-2, these confidential portions have been
omitted from this exhibit and filed separately with the Securities and Exchange Commission.
72
EXHIBIT 21.1 - - SUBSIDIARIES OF THE REGISTRANT
Name of Subsidiary
CorVel Health Care Organization
State of Incorporation
California
Relationship to Registrant
wholly-owned subsidiary
CorVel Healthcare Corporation
California
wholly-owned subsidiary
CorVel Enterprise Comp, Inc.
of New York
New York
wholly-owned subsidiary
CorVel Enterprise Comp, Inc.
Delaware
wholly-owned subsidiary
CorVel IME Corporation
New York
wholly-owned subsidiary
CareIQ, Inc.
Minnesota
wholly-owned subsidiary
Enterprise Comp, Inc.
Delaware
wholly-owned subsidiary
CorVel Ohio MCO, Inc.
Ohio
wholly-owned subsidiary
Eagle Claims Services, Inc.
New York
wholly-owned subsidiary
73
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-144402,
333-58455, 333-16379, 333-107428, 333-128739, 333-94440, 333-53684, 333-48186, 333-42554, and 333-42424)
of CorVel Corporation (the “Company”) of our report dated June 10, 2013, relating to the Company’s consolidated
financial statements, financial statement schedule and internal controls included in the Company’s Annual Report on
Form 10-K for the fiscal year ended March 31, 2013.
Irvine, California
June 10, 2013
HASKELL & WHITE LLP
74
Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, V. Gordon Clemons, certify that:
1. I have reviewed this annual report on Form 10-K of CorVel Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this
report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over
financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the
end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting
that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board
of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information; and
significant role in the registrant’s internal control over financial reporting.
(b) Any fraud, whether or not material, that involves management or other employees who have a
Date: June 10, 2013
/s/ V. Gordon Clemons
V. Gordon Clemons
Chairman of the Board, President, Chief Executive
Officer (Principal Executive Officer)
75
Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Scott R. McCloud, certify that:
1. I have reviewed this annual report on Form 10-K of CorVel Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this
report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over
financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the
end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting
that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board
of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information; and
significant role in the registrant’s internal control over financial reporting.
(b) Any fraud, whether or not material, that involves management or other employees who have a
Date: June 10, 2013
/s/ Scott R. McCloud
Scott R. McCloud
Chief Financial Officer (Principal Financial
and Accounting Officer)
76
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of CorVel Corporation (the “Registrant”) on Form 10-K for the fiscal
year ended March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Annual
Report”), I, V. Gordon Clemons, Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Annual Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities
Exchange Act of 1934; and
(2) the information contained in the Annual Report fairly presents, in all material respects, the financial
condition and results of operations of the Registrant.
/s/ V. Gordon Clemons
V. Gordon Clemons
Chairman of the Board, President, Chief Executive Officer
(Principal Executive Officer)
June 10, 2013
A signed original of this written statement required by Section 906, or other document authenticating,
acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to CorVel Corporation and will be retained by CorVel
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies this Annual Report and is being furnished pursuant to Item 601(b)(32) of Regulation
S-K promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), and pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
This certification shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the
Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or
otherwise subject to the liability of that section, or incorporated by reference into any filing under the Securities Act
or the Exchange Act, except as shall be expressly set forth by specific incorporation by reference in such a filing.
77
Exhibit 32.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of CorVel Corporation (the “Registrant”) on Form 10-K for the fiscal
year ended March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Annual
Report”), I, Scott R. McCloud, Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Annual Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities
Exchange Act of 1934; and
(2) the information contained in the Annual Report fairly presents, in all material respects, the financial
condition and results of operations of the Registrant.
/s/ Scott R. McCloud
Scott R. McCloud
Chief Financial Officer (Principal Financial
and Accounting Officer)
June 10, 2013
A signed original of this written statement required by Section 906, or other document authenticating,
acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to CorVel Corporation and will be retained by CorVel
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies this Annual Report and is being furnished pursuant to Item 601(b)(32) of Regulation
S-K promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), and pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
This certification shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the
Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or
otherwise subject to the liability of that section, or incorporated by reference into any filing under the Securities Act
or the Exchange Act, except as shall be expressly set forth by specific incorporation by reference in such a filing.
78
www.corvel.com